Section 46

EurekaMag PDF full texts Chapter 45,276


Erden, B.F.; Ulak, G.; Yildiz, F.; Utkan, T.; Ozdemirci, S.; Gacar, N. 2001: Antidepressant, anxiogenic, and antinociceptive properties of levofloxacin in rats and mice. Pharmacology, Biochemistry, and Behavior 68(3): 435-441
Dollow, S. 1996: Antidepressant-associated fatal intrahepatic cholestasis. Lancet 347(9010): 1268-1269
Bottlender, R.; Rudolf, D.; Strauss, A.; Möller, H.J. 1998: Antidepressant-associated maniform states in acute treatment of patients with bipolar-i depression. European Archives of Psychiatry and Clinical Neuroscience 248(6): 296-300
Popli, A.P.; Tanquary, J. 1994: Antidepressant-associated seizures. Journal of Clinical Psychiatry 55(6): 267
Furukawa, T. 1999: Antidepressant-benzodiazepine combination therapy. American Journal of Psychiatry 156(11): 1840
Simpson, H.B.; Liebowitz, M.R. 1996: Antidepressant-induced cycle acceleration in bipolar disorder. American Journal of Psychiatry 153(9): 1239
Furukawa, T. 1996: Antidepressant-induced manic switches. American Journal of Psychiatry 153(10): 1370
Ashton, A.K.; Ahrens, K.; Gupta, S.; Masand, P.S. 2000: Antidepressant-induced sexual dysfunction and Ginkgo Biloba. American Journal of Psychiatry 157(5): 836-837
Robinson, M.J. 2001: Antidepressant-induced sexual dysfunction in adolescence. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 46(2): 185
Ellison, J.M. 1998: Antidepressant-induced sexual dysfunction: review, classification, and suggestions for treatment. Harvard Review of Psychiatry 6(4): 177-189
Bürgi, S.; Baltensperger, K.; Honegger, U.E. 2003: Antidepressant-induced switch of beta 1-adrenoceptor trafficking as a mechanism for drug action. Journal of Biological Chemistry 278(2): 1044-1052
Kinney, G.G.; Griffith, J.C.; Hudzik, T.J. 1998: Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule. Behavioural Pharmacology 9(4): 309-318
Blair, D.T. 1996: The placebogenic phenomenon: art in psychiatric nursing. Journal of Psychosocial Nursing and Mental Health Services 34(8): 11-15
Collins, S.L.; Moore, R.A.; McQuayHJ; Wiffen, P. 2000: Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. Journal of Pain and Symptom Management 20(6): 449-458
Kusumakar, V. 2002: Antidepressants and antipsychotics in the long-term treatment of bipolar disorder. Journal of Clinical Psychiatry 63(Suppl 10): 23-28
Ito, S.; Koren, G. 1997: Antidepressants and breast-feeding. American Journal of Psychiatry 154(8): 1174
Dodd, S.; Buist, A.; Norman, T.R. 2000: Antidepressants and breast-feeding: a review of the literature. Paediatric Drugs 2(3): 183-192
Miller, L.G. 1993: Antidepressants and cancer: cause for concern?. Journal of Clinical Psychopharmacology 13(1): 1-2
Hwang, M.; Riggs, B.J.; Katz, J.; Seyfert, D.; Northington, F.; Shenandoah, R.; Burd, I.; McArthur, J.; Darge, K.; Thimm, M.A.; Huisman, T.A.G.M. 2018: Advanced Pediatric Neurosonography Techniques: Contrast-Enhanced Ultrasonography, Elastography, and Beyond. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging 28(2): 150-157
Curtis, D. 2001: Antidepressants and counselling for major depression in primary care. Counselling is not demonstrably as effective as drug treatment for depression. Bmj 323(7307): 282-283
Thornett, A.M. 2001: Antidepressants and counselling for major depression in primary care. Measuring preference in primary care studies could be improved. Bmj 323(7307): 282; Author Reply 283
Blakley, B.W. 1999: Antidepressants and dizziness. Journal of Otolaryngology 28(6): 313-317
Morris, M.R. 1999: Antidepressants and drug interactions: prescriber beware. Journal of American College Health: J of Ach 47(4): 191-192
Slaughter, J.R.; Beck, D.A.; McDonald, A. 1999: Antidepressants and falls among nursing home residents. New England Journal of Medicine 340(4): 320
D'Sa, C.; Duman, R.S. 2002: Antidepressants and neuroplasticity. Bipolar Disorders 4(3): 183-194
Hammond, M.F.; Evans, M.E.; Lye, M. 1993: Antidepressants and old people. Lancet 342(8865): 244-245
Meek, J.K.; Kablinger, A. 1998: Antidepressants and posttraumatic stress disorder. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 150(10): 487-489
Chebili, S.; Abaoub, A.; Mezouane, B.; Le Goff, J.F. 1998: Antidepressants and sexual stimulation: the correlation. L'Encephale 24(3): 180-184
Gambassi, G.; Bernabei, R. 1999: Antidepressants and smoking cessation. Archives of Internal Medicine 159(11): 1257-1258
Bryois, C.; Delacrausaz, P.; Didisheim, S. 1999: Antidepressants and somatic disease. Praxis 88(34): 1351-1356
Isacsson, G.; Rich, C.L.; Bergman, U. 1996: Antidepressants and suicide prevention. American Journal of Psychiatry 153(12): 1659
Markowitz, J.C. 2001: Antidepressants and suicide risk. British Journal of Psychiatry: the Journal of Mental Science 178: 477
Kurdyak, P.A.; Gnam, W.H.; Streiner, D.L. 2002: Antidepressants and the risk of breast cancer. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 47(10): 966-970
Mackay, F.J.; Dunn, N.R.; Mann, R.D. 1999: Antidepressants and the serotonin syndrome in general practice. British Journal of General Practice: the Journal of the Royal College of General Practitioners 49(448): 871-874
Golden, R.N.; Evans, D.L. 1994: Antidepressants and tinnitus. Archives of Internal Medicine 154(12): 1411
Po, A.L. 1999: Antidepressants and upper gastrointestinal bleeding. Bmj 319(7217): 1081-1082
Dinan, T.G.. 2000: Antidepressants and violence: cause for concern or media hype?. Human Psychopharmacology 15(6): Iii-Iiv
Lichtigfeld, F.J.; Gillman, M.A. 1998: Antidepressants are not drugs of abuse or dependence. Postgraduate Medical Journal 74(875): 529-532
Hamburg, S.R. 2000: Antidepressants are not placebos. American Psychologist 55(7): 761-762
Haddad, P.; Anderson, I. 1999: Antidepressants aren't addictive: clinicians have depended on them for years. Journal of Psychopharmacology 13(3): 291-292; Discussion 299
Sawynok, J. 2001: Antidepressants as analgesics: an introduction. Journal of Psychiatry and Neuroscience: Jpn 26(1): 20
Olié, J.P.; Elomari, F.; Spadone, C.; Lépine, J.P. 2002: Antidepressants consumption in the global population in France. L'Encephale 28(5 Part 1): 411-417
Bennett, R.M. 2002: Antidepressants do not have better results than placebo in the treatment of fibromyalgia in Brazil. Current Rheumatology Reports 4(4): 284-285
Robbins, A. 2002: Antidepressants for bipolar depression. Psychiatric Services 53(10): 1331
Reisner, L. 2003: Antidepressants for chronic neuropathic pain. Current Pain and Headache Reports 7(1): 24-33
Dionne, R.A. 2000: Antidepressants for chronic orofacial pain. Compendium of Continuing Education in Dentistry 21(10): 822
Lima, M.S.; Reisser, A.A.; Soares, B.G.; Farrell, M. 2001: Antidepressants for cocaine dependence. Cochrane Database of Systematic Reviews 4: Cd002950
Gill, D.; Hatcher, S. 2000: Antidepressants for depression in medical illness. Cochrane Database of Systematic Reviews 4: Cd001312
Gill, D.; Hatcher, S. 2000: Antidepressants for depression in people with physical illness. Cochrane Database of Systematic Reviews 2: Cd001312
Anonymous 1999: Antidepressants for fainting spells. Harvard heart letter: from Harvard Medical School 10(1): 3
Haddad, P. 1999: Antidepressants for old people. Elderly people are particularly prone to develop side effects. Bmj 319(7213): 850; Author Reply 851
Baldwin, R.C. 1999: Antidepressants for old people. GPs should become familiar with one or two antidepressants from each class. Bmj 319(7213): 849
McAllister-Williams, R.H. 1999: Antidepressants for old people. Lack of evidence of efficacy is not evidence of lack of efficacy. Bmj 319(7213): 850-851
Gordon, C. 1999: Antidepressants for old people. Research on antidepressants in the elderly population is scarce. Bmj 319(7213): 851
Whitehead, C.; Moss, S.; Cardno, A.; Lewis, G. 2002: Antidepressants for people with both schizophrenia and depression. Cochrane Database of Systematic Reviews 2: Cd002305
Anonymous 2002: Antidepressants for the heart. Harvard Mental Health Letter 18(9): 7
Bains, J.; Birks, J.; Dening, T. 2002: Antidepressants for treating depression in dementia. Cochrane Database of Systematic Reviews 4: Cd003944
Efremova, I.; Asnis, G. 1998: Antidepressants in depressed patients with irritable bowel syndrome. American Journal of Psychiatry 155(11): 1627-1628
Baldwin, R.C. 1995: Antidepressants in geriatric depression: what difference have they made?. International Psychogeriatrics 7 Suppl: 55-68
Carter, G.T.; Sullivan, M.D. 2002: Antidepressants in pain management. Current Opinion in Investigational Drugs 3(3): 454-458
Ratan, D.A.; Friedman, T. 1995: Antidepressants in pregnancy and breastfeeding. British Journal of Psychiatry: the Journal of Mental Science 167(6): 824
Teasell, R.W.; Merskey, H.; Deshpande, S. 1999: Antidepressants in rehabilitation. Physical Medicine and Rehabilitation Clinics of North America 10(2): 237-53 Vii
Nardi, A.E. 2001: Antidepressants in social anxiety disorder. Arquivos de Neuro-Psiquiatria 59(3-A): 637-642
Paykel, E.S. 2000: Antidepressants in the 1990s. Epidemiologia E Psichiatria Sociale 9(3): 152-155
Mays, T.A. 2001: Antidepressants in the management of cancer pain. Current Pain and Headache Reports 5(3): 227-236
Punay, N.C.; Couch, J.R. 2003: Antidepressants in the treatment of migraine headache. Current Pain and Headache Reports 7(1): 51-54
Balon, R. 1996: Antidepressants in the treatment of premature ejaculation. Journal of Sex and Marital Therapy 22(2): 85-96
Li, X.M.; Juorio, A.V.; Bennett, V.L.; Shrikhande, S.; Bowen, R.C. 2000: Antidepressants increase gene expression of a neuroprotective enzyme. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(3): 296
Chandra, R.; Bhatia, M.S. 2001: Antidepressants induced sexual dysfunctions. Indian Journal of Medical Sciences 55(3): 139-148
Dwivedi, Y.; Agrawal, A.K.; Rizavi, H.S.; Pandey, G.N. 2002: Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain. Neuropharmacology 43(8): 1269-1279
Bosch, T.M.; van der Werf, T.S.; Uges, D.R.; Ligtenberg, J.J.; Fijen, J.W.; Tulleken, J.E.; Zijlstra, J.G. 2000: Antidepressants self-poisoning and ICU admissions in a university hospital in The Netherlands. Pharmacy World and Science: Pws 22(3): 92-95
Moncrieff, J.; Wessely, S.; Hardy, R. 2001: Antidepressants using active placebos. Cochrane Database of Systematic Reviews 2: Cd003012
Bacaltchuk, J.; Hay, P. 2001: Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database of Systematic Reviews 4: Cd003391
Bacaltchuk, J.; Hay, P.; Trefiglio, R. 2001: Antidepressants versus psychological treatments and their combination for bulimia nervosa. Cochrane Database of Systematic Reviews 4: Cd003385
Lépine, J.P. 1996: Antidepressants, anxiety and depression disorders. L'Encephale 22(Special Issue 7): 15-17
Palmer, K.; Dalton, J. 1999: Antidepressants, anxiolytics and antipsychotics in Japan. Summary and table. Drugs in R&d 2(1): 45-46
Partonen, T. 1994: Antidepressants, melatonin and seasonal depression. Duodecim; Laaketieteellinen Aikakauskirja 110(21): 2030-2032
Sarko, J. 2000: Antidepressants, old and new. a review of their adverse effects and toxicity in overdose. Emergency Medicine Clinics of North America 18(4): 637-654
Miller, J.L. 1999: Antidepressants, rhinosinusitis are topics of new AHCPR evidence reports. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 56(9): 853
Kuhar, M.B.; Kuhar, B.M. 1996: Antidepressants. A pharmacological update and rationale for treatment. Aaohn Journal: Official Journal of the American Association of Occupational Health Nurses 44(11): 554-65; Quiz 566-8
Mischoulon, D. 2000: Antidepressants: choices and controversy. Health News 6(6): 4-5
Stahl, S.M. 1999: Antidepressants: the blue-chip psychotropic for the modern treatment of anxiety disorders. Journal of Clinical Psychiatry 60(6): 356-357
Håberg, M.; Matheson, I. 1997: Antidepressive agents and breast feeding. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(27): 3952-3955
Rück, C. 2000: Antidepressive agents and cost-efficiency. Lakartidningen 97(23): 2898-2899
Danion, J.M. 1993: Antidepressive agents and memory. L'Encephale 19(Special Issue 2): 417-422
Chabannes, J.P. 1995: Antidepressive agents and neuroses. L'Encephale 21(Special Issue 4): 7-9
Rosenberg, R. 1998: Antidepressive agents and panic attacks. Ugeskrift for Laeger 160(6): 852
Vollset, P. 1998: Antidepressive agents and physical therapy. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(11): 1761
Tajima, O.; Mitsuhashi, T.; Murata, S.; Sugiyama, T.; Nara, K.; Kogure, M.; Takemasa, K. 1996: Antidepressive agents and the cerebral signal transduction system--hippocampal neuromodulation and the action mechanism of antidepressants. Seishin Shinkeigaku Zasshi 98(11): 909-915
Korthals Altes, M.; Kurz, A. 2000: Antidepressive agents in dementia. Zeitschrift für Gerontologie und Geriatrie 33(5): 396-400
Peyré, F. 1994: Antidepressive agents in non-depressive disorders. La Revue du Praticien 44(17): 2299-2301
Koczorek, M. 2001: Antidepressive agents in pain therapy. Pain memory eliminated. MMW Fortschritte der Medizin 143(42): 18
Hansen, E.S.; Bolwig, T.G. 1997: Antidepressive agents in the treatment of obsessive-compulsive disorder. Ugeskrift for Laeger 159(2): 183-184
Bougerol, T. 1994: Antidepressive agents of recent generation. La Revue du Praticien 44(17): 2293-2298
Asing-Johanson, E.; Hofvander, Y. 1993: Children are losers in the African AIDS epidemic. Protective network of the extended family is diminishing. Lakartidningen 90(41): 3565-3566
Eschalier, A. 1995: Antidepressive agents, the dorsal horn and pain. Cahiers d'Anesthesiologie 43(4): 357-361
Cuche, H.; Gérard, A. 1994: Antidepressive agents: benefits/risks. L'Encephale 20(Special Issue 1): 203-207
Cuenca, E.; Alamo, C.; Coullaut-Jáuregui, J. 1997: Antidepressive agents: classification and mechanism of action. Revista Clinica Espanola 197(Suppl 3): 44-47
Haustein, K.O. 2000: Antidepressive drug against nicotine. a method for smoking cessation. MMW Fortschritte der Medizin 142(51-52): 44-46
Gram, L.F. 1994: Antidepressive drug therapy, suicidal tendency and suicide, 2 cases reported in connection with moclobemide (Aurorix) therapy. Ugeskrift for Laeger 156(38): 5542
Petit, M. 1994: Antidepressive drug treatment of the schizophrenic patient. L'Encephale 20(Special Issue 4): 667-674
Masi, G.; Marcheschi, M. 1996: Antidepressive drugs in children and adolescents. Minerva Pediatrica 48(1-2): 33-47
Bernardo, M. 1997: Antidepressive drugs: yesterday, today and tomorrow?. Medicina Clinica 108(5): 180-181
Shiloh, R.; Weizman, A.; Weizer, N.; Dorfman-Etrog, P.; Munitz, H. 2001: Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial. Harefuah 140(5): 369-373; 456
Anonymous 1997: Antidepressive effectiveness and good tolerance. Der Nervenarzt 68(2 Suppl): 5-7
Madsen, H.G. 1993: Antidepressive therapy. Ugeskrift for Laeger 155(31): 2416
Haug, H.J.; Fähndrich, E. 2000: Antidepressive therapy by modifying sleep. Therapeutische Umschau. Revue Therapeutique 57(2): 76-80
Hébert, M. 1999: Antidepressive therapy for smoking cessation. Presse Medicale 28(17): 915
Eller, M. 1998: Antidepressive therapy--safety in steering in spite of it. Fortschritte der Medizin 116(6): 18-19
Anonymous 2000: Antidepressive therapy. Hypericum extract Ll 160 highly effective. MMW Fortschritte der Medizin 142(3): 52-53
Einecke, D. 2001: Neuromuscular blockade with botulinum toxin. from toxin to therapeutic agent. MMW Fortschritte der Medizin 143(Suppl 2): 95-96
Vérot, J.P.; Pécot, F.; Uribé, M. 1999: Antidepressive treatment and role of the nurse. Soins; la Revue de Reference Infirmiere 640: 43-45
Mabeck, C.E.; Rosenberg, R. 1997: Antidepressive treatment in general practice. Ugeskrift for Laeger 159(3): 264
Anonymous 1997: Antidepressives affect fetal outcome. FortschrittederNeurologie-Psychiatrie 65(11):Xi
Herberg, K.W. 1994: Antidepressives and traffic safety. Fortschritte der Neurologie-Psychiatrie 62(Suppl 1): 24-28
Van Schayck, R.; Volz, H.P.; Meissner, W.; Malessa, R. 1998: Antidepressives in chronic pain. Significant analgesic therapy option. Medizinische Monatsschrift für Pharmazeuten 21(10): 304-313
Svestka, J. 1994: Antidepressives of the 3rd, 4th and 5th generation. Ceskoslovenska Psychiatrie 90(1): 3-19
Auzzas, L.; Palomba, M.; Boatto, G.; Manconi, P.; Pau, A.; Becciu, A.; Cerri, R.; Tullio, V.; Roana, J.; Carlone, N. 2000: Antidermatophytic action of new 1-naphthylmethyl and benzo[b]thiophen-7-ylmethyl hydrazones related to inhibitors of squalene epoxidase. Die Pharmazie 55(7): 483-489
Bearden; Boggild; Boissevain; Christiansen; Conin; Dodd; Erazmus; Esumi; Fabjan; Ferenc; Franz; Gaardhoje; Hansen; Hansen; Hardtke; van Hecke H; Holzer; Humanic; Hummel; Jacak; Kaimi; Kaneta; Kohama; Kopytine; Leltchouk; Ljubicic 2000: Antideuteron production in 158A GeV/c Pb + Pb collisions. Physical Review Letters 85(13): 2681-2684
Nagle; Kumar; Bennett; Coe; Diebold; Pope; Jahns; Sorge 1994: Antideuteron production in high energy heavy ion collisions. Physical Review Letters 73(18): 2417-2420
Armstrong; Barish; Batsouli; Bennett; Bertaina; Chikanian; Coe; Cormier; Davies; Dover; Fachini; Fadem; Finch; George; Greene; Haridas; Hill; Hirsch; Hoversten; Huang; Jaradat; Kumar; Lainis; Lajoie; Li; Libby 2000: Antideuteron yield at the AGS and coalescence implications. Physical Review Letters 85(13): 2685-2688
Robles, N.R.; Blanco, J. 2002: Antidiabetic agents and renal insufficiency. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 22(4): 325-328
Simmons, M. 2001: Implementation of a patient falls risk-management strategy. Professional Nurse 17(3): 168-171
Rao, B.K.; Kesavulu, M.M.; Giri, R.; Appa Rao, C. 1999: Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. fruit powder in alloxan-diabetic rats. Journal of Ethnopharmacology 67(1): 103-109
Rojas Hidalgo, E. 1997: Antidiabetic biguanides and lactic acidosis. Revista Clinica Espanola 197(8): 568-573
Nauck, M. 2001: Antidiabetic combination therapy. Der Internist 42(Suppl 1): S20-S27
Landgraf, R. 2000: Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients. MMW Fortschritte der Medizin 142(28-29): 29-30
Charles, M.A. 2000: Antidiabetic drugs and the vascular system. Diabetes Technology and Therapeutics 2(2): 273-274
Yang, X.B.; Huang, Z.M.; Cao, W.B.; Zheng, M.; Chen, H.Y.; Zhang, J.Z. 2000: Antidiabetic effect of Oenanthe javanica flavone. Acta Pharmacologica Sinica 21(3): 239-242
Oku, A.; Ueta, K.; Nawano, M.; Arakawa, K.; Kano-Ishihara, T.; Matsumoto, M.; Saito, A.; Tsujihara, K.; Anai, M.; Asano, T. 2000: Antidiabetic effect of T-1095, an inhibitor of Na(+)-glucose cotransporter, in neonatally streptozotocin-treated rats. European Journal of Pharmacology 391(1-2): 183-192
Han, M.-K.; Kim, S.-J.; Park, Y.-R.; Shin, Y.-M.; Park, H.-J.; Park, K.-J.; Park, K.-H.; Kim, H.-K.; Jang, S.-I.; An, N.-H.; Kim, U.-H. 2002: Antidiabetic effect of a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, through CD38 dimerization and internalization. Journal of Biological Chemistry 277(7): 5315-5321
Kiho, T.; Kochi, M.; Usui, S.; Hirano, K.; Aizawa, K.; Inakuma, T. 2001: Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H). Biological and Pharmaceutical Bulletin 24(12): 1400-1403
Girard, J. 2001: Antidiabetic effect of thiazolidinediones. Journees Annuelles de Diabetologie de l'Hotel-Dieu 2001: 33-45
Rao, R.M.; Salem, F.A.; Gleason-Jordan, I. 1998: Antidiabetic effects of a dietary supplement "Pancreas Tonic". Journal of the National Medical Association 90(10): 614-618
Yoshikawa, M.; Shimada, H.; Nishida, N.; Li, Y.; Toguchida, I.; Yamahara, J.; Matsuda, H. 1998: Antidiabetic principles of natural medicines. II. Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): structures of myrciacitrins i and Ii and myrciaphenones a and B. Chemical and Pharmaceutical Bulletin 46(1): 113-119
Matsuda, H.; Murakami, T.; Yashiro, K.; Yamahara, J.; Yoshikawa, M. 1999: Antidiabetic principles of natural medicines. IV. Aldose reductase and qlpha-glucosidase inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of a new friedelane-type triterpene, kotalagenin 16-acetate. Chemical and Pharmaceutical Bulletin 47(12): 1725-1729
Maher, J. 2001: Antidiabetic treatment for NASH?. Hepatology 33(5): 1338-1339
Smith, N.L.; Heckbert, S.R.; Bittner, V.A.; Savage, P.J.; Barzilay, J.I.; Dobs, A.S.; Psaty, B.M. 1999: Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997. Diabetes care 22(5): 736-742
Yoshikawa, M.; Matsuda, H. 2000: Antidiabetogenic activity of oleanolic acid glycosides from medicinal foodstuffs. Biofactors 13(1-4): 231-237
Maksimovic, D.; Mostarica Stojkovic, M.; Stosic-Grujicic, S. 2002: Antidiabetogenic effect of mycophenolate mofetil is associated with down-regulation of adhesive interactions and autoreactive cell activation. Annals of the new York Academy of Sciences 958: 148-151
Ippoliti, C. 1998: Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 55(15): 1573-1580
Aikawa, N.; Horikoshi, K.; Maeda, H.; Kobayashi, H.; Ohmori, K. 1999: Antidiarrheal effects of zaldaride maleate after oral, intravenous and subcutaneous administration to rats. Japanese Journal of Pharmacology 81(4): 397-400
Fallows, G.A.; Bursey, R.F. 1999: Antidiarrheal therapy. Canadian Journal of Gastroenterology 13(3): 207-208
Zavala, M.A.; Pérez, S.; Pérez, C.; Vargas, R.; Pérez, R.M. 1998: Antidiarrhoeal activity of Waltheria americana, Commelina coelestis and Alternanthera repens. Journal of Ethnopharmacology 61(1): 41-47
Offiah, V.N.; Chikwendu, U.A. 1999: Antidiarrhoeal effects of Ocimum gratissimum leaf extract in experimental animals. Journal of Ethnopharmacology 68(1-3): 327-330
Sergienko, V.I.; Sivov, I.G.; Malyshev, N.A. 1999: Antidiphtheria activity of epidermal growth factor precursor fragment. Biulleten' Eksperimental'noi Biologii i Meditsiny 127(1): 92-94
Durbacă, S.; Serban, R.; Ulmeanu, V. 1998: Antidiphtheria and antitetanus immunity in various age groups (0-70 yrs) in Romania. Roumanian Archives of Microbiology and Immunology 57(1): 45-51
Durbacă, S. 1996: Antidiphtheria and antitetanus immunity of recruits in Romania. Roumanian Archives of Microbiology and Immunology 55(4): 295-303
Nikitiuk, N.F. 2001: Antidiphtheria immunity in adult population of the Orenburg region. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 53-56
Todd, G. 1997: Antidiscrimination: the path of a legislative issue. Aana Journal 65(5): 424-427
Gray, D.A.; Maloney, S.K. 1998: Antidiuretic hormone and angiotensin Ii plasma concentrations in febrile Pekin ducks. Journal of Physiology 511: 605-610
Sawada, S.; Takeda, T.; Saito, H. 1997: Antidiuretic hormone and psychosomatic aspects in Menière's disease. Acta Oto-Laryngologica. Supplementum 528: 109-112
Sheikh-Hamad, D.; Ayus, C.J. 1998: Antidiuretic hormone and renal clearance of uric acid. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 32(4): 692
Taniguchi, H.; Yokoyama, A.; Yamazaki, S.; Nakamura, S.; Ohki, O.; Matsunaga, T.; Yokozeki, H.; Nishioka, K.; Katayama, I. 1999: Antidiuretic hormone in severe cases of atopic dermatitis. Arerugi 48(1): 33-39
McBroom, M.J.; Qureshi, A.; Davidson, N. 1998: Antidiuretic hormone infusion reduces taurine and NaCl-induced hypernatremia in the rat. Amino Acids 15(1-2): 89-97
Hazebroek, E.J.; de Vos tot Nederveen Cappel, R.; Gommers, D.; van Gelder, T.; Weimar, W.; Steyerberg, E.W.; Bonjer, H.J.; IJzermans, J.N.M. 2002: Antidiuretic hormone release during laparoscopic donor nephrectomy. Archives of Surgery 137(5): 600
Antkiewicz-Michaluk, L.; Michaluk, J.; Romańska, I.; Papla, I.; Vetulani, J. 2000: Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol. Journal of Neural Transmission 107(8-9): 1009-1019
Dos Reys, L.L. 1994: Antidoping control. from a positive result to the consequences. Acta Medica Portuguesa 7(5): 291-295
Li, Y.; Liu, X.; Xue, S.Z. 1998: Antidotal effect of glucoside extracted from Astragalus membranaceus on dimethoate intoxication in guinea pigs. La Medicina del Lavoro 89(Suppl 2): S136-S141
Di, Y.F. 1993: Antidotal effect of sodium dimercapto-propane sulphonate in the treatment of acute poisoning of 2-dimethylamino-1,3-histhio-sulfopropanedisodium salt in 20 cases. Zhonghua Nei Ke Za Zhi 32(12): 827
Qiu, Z.; Lan, H.; Zhang, S.; Xia, Y.; Huang, S. 2002: Antidotal effects of vitamin B(6) and sodium dimercaptopropane sulfonate on acute poisoning with tetramethylene disulphotetramine in animals. Zhonghua Nei Ke Za Zhi 41(3): 186-188
Paloucek, F. 1999: Antidotal flumazenil use--the protamine of the 90s. Critical Care Medicine 27(1): 10-11
Mottola, C.A.; Murphy, P. 2001: Antidote Dilemma--an activity to promote critical thinking. Journal of Continuing Education in Nursing 32(4): 161-164
Solheim, L.; Andrew, E.; Jacobsen, D. 2002: Antidote availability in Norway. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(11): 1111-1113
Bailey, B.; Bussières, J.F. 2000: Antidote availability in Quebec hospital pharmacies: impact of N-acetylcysteine and naloxone consumption. Canadian Journal of Clinical Pharmacology 7(4): 198-204
Gilpin, B.; Ballin, S. 1996: Antidote for America's leading pediatric disease. Circulation 94(3): 233
Mycyk, M.B.; Leikin, J.B. 2003: Antidote review: fomepizole for methanol poisoning. American Journal of Therapeutics 10(1): 68-70
Anonymous 1997: Antidotes dangerously understocked in Colorado, Montana, and Nevada. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 54(1): 16 19
Fujii, C. 2000: Antidotes for poisoning and medication overdosage. Nihon Geka Gakkai Zasshi 101(11): 794-798
Higgins, M.A.; Evans, R. 2000: Antidotes--inappropriate timely availability. Human and Experimental Toxicology 19(9): 485-488
Nogué, S.; Soy, D.; Munné, P.; Millá, J. 1997: Antidotes: availability, use and cost in hospital and extra-hospital emergency services of Catalonia (Spain). Archives of Toxicology. Supplement. 19: 299-304
Papoyan, E.V. 1997: Antidromal and synaptic activation of neurons of the associative parietal cortex of the cat brain elicited by spike activity from the intrinsic nuclei of the pons. Neuroscience and Behavioral Physiology 27(6): 695-701
Papoian, E.V. 1996: Antidromal and synaptic activation of the neurons of the associative parietal cortex in cats evoked by impulses from the pontine nuclei proper. Fiziologicheskii Zhurnal Imeni I.M. Sechenova 82(1): 10-17
Asari, J.; Suzuki, K.; Matsumoto, M.; Sasaki, T.; Kodama, N. 2001: Antidromic effect of calcitonin gene-related peptide containing nerves on cerebral arteries in rats--a possible role of sensory nerves on cerebral circulatio. Fukushima Journal of Medical Science 47(2): 75-84
Man, D.C.; Sarter, B.H.; Coyne, R.F.; Callans, D.J.; Schwartzman, D.; Gottlieb, C.D.; Marchlinski, F.E. 1999: Antidromic reciprocating tachycardia in patients with paraseptal accessory pathways: importance of critical delay in the reentry circuit. Pacing and Clinical Electrophysiology: Pace 22(2): 386-389
Brown, M.C. 1994: Antidromic responses of single units from the spiral ganglion. Journal of Neurophysiology 71(5): 1835-1847
Kim, W.; Kim, H.J.; Blumenthal, F.S.; Joynt, R.L. 1993: Antidromic sensory nerve conduction studies of medial and lateral plantar nerves in normals. Electromyography and Clinical Neurophysiology 33(5): 289-294
Tashima, K.; Takeda, T.; Saito, H. 1994: Antidromically evoked facial nerve response in guinea pigs with partial nerve injury. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 1994: S212-S213
Nakatani, H.; Takeda, T.; Saito, H.; Haji, T. 1994: Antidromically evoked facial nerve responses in human subjects: modification of recording techniques. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 1994: S214-S215
McAuley, L. 2001: Inhaled insulin for the treatment of diabetes mellitus. Issues in Emerging Health Technologies 66(18): 1-4
Zoler, M.L. 1988: Antidumping rules finally emerge. Medical World News 29(14): 39
Haugh, K.H. 2002: Antidysrhythmic agents at the turn of the twenty-first century: a current review. Critical Care Nursing Clinics of North America 14(1): 53-69
Fulton, S.; Jackimczyk, K.C. 2000: Antidysrhythmics. Emergent. Emergency Medicine Clinics of North America 18(4): 655-669
Smyth, J.A. 1974: Antidysthanasia contracts: a proposal for legalizing death with dignity. Pacific Law Journal 5(2): 738-763
Sokolík, J.; Karovicová, K.; Tumová, I.; Blahová, M.; Svec, P. 1998: Antiedema activity of selected compounds with a gallate skeleton. Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 47(3): 138-140
Sokolík, J.; Tumová, I.; Blahová, M.; Harisová, E.; Svec, P. 1998: Antiedematous activity of certain arylcarboxylate copper aquacomplexes. Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 47(2): 91-94
Mims, J.L.; Wood, R.C. 1999: Antielevation syndrome after bilateral anterior transposition of the inferior oblique muscles: incidence and prevention. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus 3(6): 333-336
Lewith, G.; Romoli, M. 1999: Antiemesis with P6 laser acupuncture in children. Forschende Komplementarmedizin 6(5): 276-278
Darmani, N.A.; Sim-Selley, L.J.; Martin, B.R.; Janoyan, J.J.; Crim, J.L.; Parekh, B.; Breivogel, C.S. 2003: Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation. European Journal of Pharmacology 459(1): 83-95
Madej, G.; Pawiński, A.; Rogowski, W.; Skoneczna, I. 1993: Antiemetic effect of ondansetron in patients treated with combined antineoplastic regimens which include cisplatin. Polski Tygodnik Lekarski 48(25-26): 560-562
Marty, M.; Richard, A.; d'Allens, H. 1993: Antiemetic effect of ondansetron in recurrent chemotherapy with cisplatin. Bulletin du Cancer 80(7): 618-623
Borgeat, A.; Stirnemann, H.R. 1998: Antiemetic effect of propofol. Der Anaesthesist 47(11): 918-924
Morita, M.; Kuwano, H.; Ohno, S.; Kitamura, K.; Sugimachi, K. 2000: Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer. Anticancer Research 20(5c): 3631-3636
Gomez-de-Segura, I.A.; Grande, A.G.; De Miguel, E. 1998: Antiemetic effects of Lerisetron in radiation-induced emesis in the dog. Acta Oncologica 37(7-8): 759-763
Goksu, S.; Kocoglu, H.; Bayazit, Y.A.; Yüksek, S.; Karci, Y.; Kanlikama, M.; Oner, U. 2002: Antiemetic effects of granisetron, droperidol and dexamethasone in otologic surgery. Auris Nasus Larynx 29(3): 253-256
Roila, F.; Ballatori, E.; Del Favero, A. 1993: Antiemetic effects of ondansetron and metopimazine. New England Journal of Medicine 329(18): 1356-1357
Minami, M.; Endo, T.; Kikuchi, K.; Ihira, E.; Hirafuji, M.; Hamaue, N.; Monma, Y.; Sakurada, T.; Tan-no, K.; Kisara, K. 1998: Antiemetic effects of sendide, a peptide tachykinin NK1 receptor antagonist, in the ferret. European Journal of Pharmacology 363(1): 49-55
Sigsgaard, T.; Herrstedt, J.; Christensen, P.; Andersen, O.; Dombernowsky, P. 2000: Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 8(3): 233-237
Takahashi, T.; Mori, K.; Suga, Y.; Tominaga, K. 1993: Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(12): 1873-1875
Hirota, T.; Honjo, T.; Kuroda, R.; Saeki, K.; Katano, N.; Sakakibara, Y.; Shimizu, H.; Fujimoto, T. 1993: Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2369-2373
Park, Y.; Hatano, Y.; Sasamoto, S.; Kato, N.; Okuyama, N.; Yamazaki, S. 1997: Antiemetic efficacy of granisetron in repeated CAF chemotherapy after breast cancer operation. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(5): 573-577
Hirota, T.; Honjo, T.; Kuroda, R.; Saeki, K.; Katano, N.; Sakakibara, Y.; Shimizu, H.; Fujimoto, T. 1993: Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2201-2205
Walder, A.D.; Aitkenhead, A.R. 1994: Antiemetic efficacy of metoclopramide when included in a patient-controlled analgesia infusion. Anaesthesia 49(9): 804-806
Ruiz de Adana, J.; Tobalina Bonis, R.; García Galán, F.; Hernández Matías, A.; Fernández Luengas, D.; Ortega Deballón, P.; López Herrero, J.; Moreno Azcoita, M. 1999: Antiemetic efficacy of ondansetron in laparoscopic cholecystectomy. a randomized, double-blind, placebo-controlled study. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 91(9): 639-643
Davies, P.R.; Warwick, P.; O'Connor, M. 1996: Antiemetic efficacy of ondansetron with patient-controlled analgesia. Anaesthesia 51(9): 880-882
Kothari, S.N.; Boyd, W.C.; Bottcher, M.L.; Lambert, P.J. 2000: Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial inpatients undergoing laparoscopic cholecystectomy. Surgical Endoscopy 14(10): 926-929
Koivuranta, M.K.; Läärä, E.; Ryhänen, P.T. 1996: Antiemetic efficacy of prophylactic ondansetron in laparoscopic cholecystectomy. a randomised, double-blind, placebo-controlled trial. Anaesthesia 51(1): 52-55
Porcel, J.M.; Salud, A.; Porta, J.; Schoenenberger, J.A. 1998: Antiemetic efficacy of subcutaneous 5-HT3 receptor antagonists in terminal cancer patients. Journal of Pain and Symptom Management 15(5): 265-266
Tanioka, Y.; Fujii, T.; Nakata, N.; Nakagawa, H.; Tanimoto, H.; Kioka, H.; Naito, H. 1994: Antiemetic efficacy of the repeated use of granisetron in multiple cycles of anti-cancer chemotherapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(16): 2803-2808
Koeller, J.M.; Aapro, M.S.; Gralla, R.J.; Grunberg, S.M.; Hesketh, P.J.; Kris, M.G.; Clark-Snow, R.A. 2002: Antiemetic guidelines: creating a more practical treatment approach. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 10(7): 519-522
Pertusa, V.; Bellver, J.; Marqués, A.; Onrubia, X.; Viñals, M.P.; Sanmiguel, G.; Seller, J.M.; Martínez-Carrasco, C. 1996: Antiemetic prophylaxis after laparoscopic cholecystectomy: comparative study of dehydrobenzperidol, metoclopramide, ondansetron and placebo. Revista Espanola de Anestesiologia y Reanimacion 43(7): 239-242
Woodward, D.K.; Sherry, K.M.; Harrison, D. 1999: Antiemetic prophylaxis in cardiac surgery: comparison of metoclopramide and ondansetron. British Journal of Anaesthesia 83(6): 933-935
Tsavaris, N.B.; Koufos, C.; Katsikas, M.; Dimitrakopoulos, A.; Athanasiou, E.; Linardaki, G. 1999: Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy. Journal of Pain and Symptom Management 18(3): 218-222
Herrstedt, J. 1998: Antiemetic research: a look to the future. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 6(1): 8-12
Spitzer, T.R.; Grunberg, S.M.; Dicato, M.A. 1998: Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 6(3): 233-236
Dicato, M. 1996: Antiemetic support: a continuous challenge. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 4(4): 261-262
Axelrod, R.S. 1997: Antiemetic therapy. Comprehensive Therapy 23(8): 539-545
Anonymous 1997: Antiemetic therapy and pharmacoeconomics. Lippincott Health Promotion Letter 2(9): 4-5
Perez, E.A.; Tiemeier, T.; Solberg, L.A. 1999: Antiemetic therapy for high-dose chemotherapy with transplantation: report of a retrospective analysis of a 5-HT(3) regimen and literature review. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 7(6): 413-424
Gerbino, P.P.; Goldsmith, M.; Kenney, J.T.; Lindley, C.; Nolte, J.; Quan, W.; Reich, P.R. 1996: Antiemetic therapy in managed care oncology: roundtable discussion. Medical Interface Suppl C: 16-35
Kaye, S.B. 1993: Antiemetic therapy--where do we go from here?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(6): 443-445
Roila, F.; Ballatori, E.; Del Favero, A. 1993: Antiemetic therapy: the state of the art. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(9): 795
Gralla, R.J. 1994: Antiemetic treatment for cancer chemotherapy: problems and progress. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2(5): 275-276
Kwon, K.T.; Rudkin, S.E.; Langdorf, M.I. 2002: Antiemetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians. Clinical Pediatrics 41(9): 641-652
Pouillart, P. 1993: Antiemetics during cytotoxic treatments. La Revue du Praticien 43(8): 1001-1006
Rizk, A.N.; Hesketh, P.J. 1999: Antiemetics for cancer chemotherapy-induced nausea and vomiting. a review of agents in development. Drugs in R&d 2(4): 229-235
Palmer, K.J.; Poole, R. 1999: Antiemetics for cancer chemotherapy-induced nausea and vomiting. Summary and table. Drugs in R&d 2(4): 237-239
Tonato, M.; Roila, F.; Del Favero, A.; Ballatori, E. 1994: Antiemetics in cancer chemotherapy: historical perspective and current state of the art. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2(3): 150-160
Billett, A.L.; Sallan, S.E. 1994: Antiemetics in children receiving cancer chemotherapy. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2(5): 279-285
Hitchcock, M.; Ogg, T.W. 1994: Antiemetics in laparoscopic surgery. British Journal of Anaesthesia 72(5): 608-609
Longueville, J. 1996: Antiemetics in oncology. Journal de Pharmacie de Belgique 51(4): 220-225
Tărmure, S.; Grigorescu, M.; Cristea, A.; Togănel, E.; Dumitra, D. 2002: Antiendomysial and antitissue transglutaminase antibodies in gluten-induced enteropathy. Romanian Journal of Gastroenterology 11(2): 91-95
Pierucci, A.; Fofi, C.; Bartoli, B.; Simonetti, B.M.; Pecci, G.; Sabbatella, L.; Di Tola, M.; Greco, R.; Anania, M.C.; Picarelli, A. 2002: Antiendomysial antibodies in Berger's disease. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 39(6): 1176-1182
Gemme, G.; Delogu, A.; Nobili, F.; Galeazzi, G.; Mariani, P.; Triglione, P.; Bonamico, M. 1993: Antiendomysial antibodies: current role in the diagnosis of celiac disease compared to antigliadin antibodies. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 15(6): 595-597
Yüce, A.; Demir, H.; Koçak, N.; Gürakan, F.; Ozen, H. 2000: Antiendomysium and antigliadin antibodies for the diagnosis of celiac disease. American Journal of Gastroenterology 95(5): 1366-1367
Cataldo, F.; Trippiedi, M.A.; Marino, V.; Maltese, I.; Traverso, G.; Paternostro, D.; Albeggiani, A. 1993: Antiendomysium antibodies and antigliadin antibodies in diagnosis and follow-up of celiac disease. Minerva Pediatrica 45(1-2): 29-33
Kotze, L.M.; Utiyama, S.R.; Nisihara, R.M.; Zeni, M.P.; de Sena, M.G.; Amarante, H.M. 2001: Antiendomysium antibodies in Brazilian patients with celiac disease and their first-degree relatives. Arquivos de Gastroenterologia 38(2): 94-103
Nasonov, E.L.; Alekberova, Z.S.; Salozhin, K.V.; Kliukvina, N.G.; Aleksandrova, E.N.; Baranov, A.A.; Le Tonqueze, M.; Youinou, P. 1996: Antiendothelial antibodies in systemic lupus erythematosus in men: the connection with kidney involvement and the antiphospholipid syndrome. Terapevticheskii Arkhiv 68(6): 46-49
Edelsten, C.; D'Cruz, D.P. 1997: Antiendothelial cell antibodies (AECA) in patients with uveoretinitis. Clinical Reviews in Allergy and Immunology 15(1): 41-52
D'Cruz, D.; Khamashta, M.; Hughes, G. 1997: Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE). Clinical Reviews in Allergy and Immunology 15(1): 53-63
Eichhorn, J.; Sima, D.; Lindschau, C.; Turowski, A.; Schmidt, H.; Schneider, W.; Haller, H.; Luft, F.C. 1998: Antiendothelial cell antibodies in thromboangiitis obliterans. American Journal of the Medical Sciences 315(1): 17-23
Cross, A.S. 1994: Antiendotoxin antibodies: a dead end?. Annals of Internal Medicine 121(1): 58-60
Bolger, A.P.; Rashid, M.; Anker, S.D. 2001: Antiendotoxin antibody levels in unstable angina: lessons from chronic heart failure and cardiopulmonary bypass. American Journal of Cardiology 88(10): 1217
Van Dervort, A.L.; Danner, R.L. 1994: Antiendotoxin approaches to septic shock therapy. Critical Care Medicine 22(4): 539-541
Likhoded, V.G.; Iakovlev, M.I.; Likhoded, N.V.; Lobova, E.A.; Chkhaidze, I.G. 1998: Antiendotoxin immunity in experimental intestinal dysbacteriosis in mice. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 14-16
Hellman, J.; Warren, H.S. 1999: Antiendotoxin strategies. Infectious Disease Clinics of North America 13(2): 371-86 Ix
Corriveau, C.C.; Danner, R.L. 1993: Antiendotoxin therapies for septic shock. Infectious Agents and Disease 2(1): 44-52
Colletti, R.C.; Dew, R.B.; Goulart, A.E. 1993: Antiendotoxin therapy in sepsis. Critical Care Nursing Clinics of North America 5(2): 345-354
Lefort, A.; Mainardi, J.L.; Tod, M.; Lortholary, O. 2000: Antienterococcal antibiotics. Medical Clinics of North America 84(6): 1471-1495
Wheeler, S.D.. 2002: Antiepileptic Drug Therapy in Migraine Headache. Current Treatment Options in Neurology 4(5): 383-394
Gupta, Y.K.; Sharma, M.; Chaudhary, G. 2001: Antiepileptic activity of Panax ginseng against pentylenetetrazole induced kindling in rats. Indian Journal of Physiology and Pharmacology 45(4): 502-506
Garne, E. 2002: Antiepileptic agents and congenital abnormalities--induced abortions should be included. Ugeskrift for Laeger 164(7): 918
Feiner, N.F. 1997: Antiepileptic drug augmentation for treatment-resistant depression. Journal of Clinical Psychiatry 58(8): 361-363
Kalachnik, J.E.; Hanzel, T.E.; Harder, S.R.; Bauernfeind, J.D.; Engstrom, E.A. 1995: Antiepileptic drug behavioral side effects in individuals with mental retardation and the use of behavioral measurement techniques. Mental Retardation 33(6): 374-382
Coulter, D.A. 1997: Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in?. Journal of Child Neurology 12(Suppl 1): S2-S9
Alldredge, B.K.; Knutsen, A.P.; Ferriero, D. 1994: Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations. Pediatric Neurology 10(2): 169-171
Kumar, N.; Khwaja, G.A.; Gupta, M.; Sharma, S. 1993: Antiepileptic drug induced osteomalacic myopathy with hyperparathyroidism and nephrolithiasis. Journal of the Association of Physicians of India 41(11): 748-749
Tun, N.Z.; Andermann, F.; Carpenter, S.; Karpati, G. 1994: Antiepileptic drug myopathy. Neurology 44(4): 777-778
McCrea, S. 2002: Antiepileptic drug overdose. Emergency Nurse: the Journal of the Rcn Accident and Emergency Nursing Association 9(9): 13-18
Mastroiacovo, P.; Botto, L.; Serafini, M.; Zampino, G. 1993: Antiepileptic drug therapy and congenital defects. Annali Dell'istituto Superiore di Sanita 29(1): 77-87
Kudo, T. 2001: Antiepileptic drug therapy for adult patients with intractable seizures. Rinsho Shinkeigaku 41(12): 1088-1090
Sirven, J.I. 2002: Antiepileptic drug therapy for adults: when to initiate and how to choose. Mayo Clinic Proceedings 77(12): 1367-1375
Pellock, J.M. 1995: Antiepileptic drug therapy in the United States: a review of clinical studies and unmet needs. Neurology 45(3 Suppl 2: S17-S24
Gram, L. 1996: Antiepileptic drug therapy--current aspects. Ugeskrift for Laeger 158(14): 1953-1954
Kaiser, C.; Asaba, G.; Mugisa, C.; Kipp, W.; Kasoro, S.; Rubaale, T.; Kabagambe, G. 1998: Antiepileptic drug treatment in rural Africa: involving the community. Tropical Doctor 28(2): 73-77
Kasteleijn-Nolstlt Trenité, D.G.; Edelbroek, P.M. 1997: Antiepileptic drug treatment in the nineties in the Netherlands. Pharmacy World and Science: Pws 19(2): 60-69
Brodtkorb, E. 1998: Antiepileptic drug treatment: clinical considerations and concerns. Progress in Brain Research 116: 395-406
Winkler, S.R. 1999: Antiepileptic drug use during breastfeeding. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 15(1): 63-66
Peytchev, L.; Atanasova, I.; Terziivanov, D. 1996: Antiepileptic drug utilization in out-patients--a prescribing pattern study. International Journal of Clinical Pharmacology and Therapeutics 34(10): 444-445
Buna, D.K. 1998: Antiepileptic drug withdrawal--a good idea?. PharmacoTherapy 18(2): 235-241
Britton, J.W. 2002: Antiepileptic drug withdrawal: literature review. Mayo Clinic Proceedings 77(12): 1378-1388
Benatar, M.G.; Sahin, M.; Davis, R.G. 2000: Antiepileptic drug-induced visual hallucinations in a child. Pediatric Neurology 23(5): 439-441
Ohtsuka, Y.; Ohtahara, S. 1994: Antiepileptic drugs. No to Shinkei 46(3): 229-237
Brodie, M.J.; Dichter, M.A. 1996: Antiepileptic drugs. New England Journal of Medicine 334(3): 168-175
Prats, J.M.; Garaizar, C.; García-Nieto, M.L.; Madoz, P. 1998: Antiepileptic drugs and atypical evolution of idiopathic partial epilepsy. Pediatric Neurology 18(5): 402-406
Campistol, J.; Chávez, B.; Vilaseca, M.A.; Artuch, R. 2000: Antiepileptic drugs and carnitine. Revista de Neurologia 30(Suppl 1): S105-S109
Martínez-Salio, A.; Porta-Etessam, J.; Berbel-Garcia, A.; Garcia-Morales, I.; de la Peña-Mayor, P.; Vicente-Fatela, L. 2001: Antiepileptic drugs and neuropathic pain. Revista de Neurologia 32(4): 345-350
Bono, A.; Beghi, E.; Bogliun, G.; Cavaletti, G.; Curtó, N.; Marzorati, L.; Frattola, L. 1993: Antiepileptic drugs and peripheral nerve function: a multicenter screening investigation of 141 patients with chronic treatment. Collaborative Group for the Study of Epilepsy. Epilepsia 34(2): 323-331
Adín, J.; Gutiérrez-Rubio, F.; Armijo, J.A. 2000: Antiepileptic drugs and the liver. Revista de Neurologia 30(Suppl 1): S94-104
De León, O.A. 2001: Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder. Harvard Review of Psychiatry 9(5): 209-222
Ramsay, R.E.; Slater, J.D. 1993: Antiepileptic drugs in clinical development. Epilepsy Research. Suppl 10: 45-67
Heaney, D.; Sander, J.W. 1998: Antiepileptic drugs in developing countries. Lancet 351(9120): 1967
Mathew, N.T. 2001: Antiepileptic drugs in migraine prevention. Headache 41 Suppl. 1: S18-S24
Di Paolo, A.; Fabbri, F.; Prota, M.; Orlandi, L.; Galasso, C. 1999: Antiepileptic drugs in pregnancy and malformations. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 21(6): 285-287
Muzina, D.J.; El-Sayegh, S.; Calabrese, J.R. 2002: Antiepileptic drugs in psychiatry-focus on randomized controlled trial. Epilepsy Research 50(1-2): 195-202
Molins, A. 2000: Antiepileptic drugs in the elderly , pregnant women, children and in systemic disorders. Revista de Neurologia 30(9): 865-872
Rozen, T.D. 2001: Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia. Headache 41(Suppl 1): S25-S32
Meldrum, B.S. 1999: Antiepileptic drugs potentiating GABA. Electroencephalography and Clinical Neurophysiology. Suppl 50: 450-457
Brodie, M.J. 1996: Antiepileptic drugs, clinical trials, and the marketplace. Lancet 347(9004): 777-779
Kito, M.; Maehara, M.; Watanabe, K. 1994: Antiepileptic drugs--calcium current interaction in cultured human neuroblastoma cells. Seizure 3(2): 141-149
Powers, J.E. 1994: Antiepileptic drugs--the drought is over. South Dakota Journal of Medicine 47(2): 63
Di Martino, A.; Tuchman, R.F. 2001: Antiepileptic drugs: affective use in autism spectrum disorders. Pediatric Neurology 25(3): 199-207
Cutrer, F.M. 2001: Antiepileptic drugs: how they work in headache. Headache 41(Suppl 1): S3-10
Mercadé Cerdá, J.M. 1996: Antiepileptic drugs: mechanism of action. Neurologia 11(Suppl 4): 93-99
Leach, J.P. 2000: Antiepileptic drugs: safety in numbers?. Seizure 9(3): 170-178
Buznego, M.T.; Pérez-Saad, H. 1999: Antiepileptic effect of Plectranthus amboinicus (lour.) Spreng. (French marjoram). Revista de Neurologia 29(4): 388-389
Murashima, Y.L.; Tada, H.; Kasamo, K.; Morooka, K.; Suzuki, J. 1993: Antiepileptic effects of allopurinol involved in hippocampal specific SOD (superoxide dismutase) induction in the mutant El mouse. Japanese Journal of Psychiatry and Neurology 47(2): 374-377
Zou, X.; Ruan, X.; Zhou, S.; Cai, Q. 1997: Antiepileptic effects of nimodipine on penicillin-induced seizures in rats. Hua Xi Yi Ke da Xue Xue Bao 28(4): 383-387
Ylinen, A. 1998: Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability. Journal of Intellectual Disability Research: Jidr 42(Suppl 1): 46-49
Bessmertny, O.; Pham, T. 2002: Antiepileptic hypersensitivity syndrome: clinicians beware and be aware. Current Allergy and Asthma Reports 2(1): 34-39
Leppik, I.E.; Wolff, D.L. 1993: Antiepileptic medication interactions. Neurologic Clinics 11(4): 905-921
Steinhoff, B.J. 1992: Antiepileptic therapy with bromides--historical and actual importance. Journal of the History of the Neurosciences 1(2): 119-123
Lemesle-Martin, M. 2001: Antiepileptic treatment in cerebral lesions: what are the indications and the main practical use?. Annales Francaises d'Anesthesie et de Reanimation 20(2): 115-122
Gilad, R.; Lampl, Y.; Eschel, Y.; Sadeh, M. 2001: Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovascular Diseases 12(1): 39-43
Persson, P.M.; Russom, A.; Tomson, T.ör. 2003: Antiepileptic treatment nearly six times more expensive since 1990. Lakartidningen 100(1-2): 42-46
Uldall, P.V. 1999: Antiepileptic treatment with lamotrigine. Ugeskrift for Laeger 161(7): 973
Satzinger, G. 1994: Antiepileptics from gamma-aminobutyric acid. Arzneimittel-Forschung 44(3): 261-266
Cloyd, J.C.; Lackner, T.E.; Leppik, I.E. 1994: Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. Archives of Family Medicine 3(7): 589-598
Brown, L.M.; Lee, Y.P.; Teyler, T.J. 1994: Antiepileptics inhibit cortical N-methyl-D-aspartate-evoked [3H]norepinephrine efflux. European Journal of Pharmacology 254(3): 307-309
Silva Brum, L.F.; Elisabetsky, E. 2000: Antiepileptogenic properties of phenobarbital: behavior and neurochemical analysis. Pharmacology Biochemistry and Behavior 67(3): 411-416
Gilmour, T.K.; Meyer, P.A.; Rytina, E.; Todd, P.M. 2001: Antiepiligrin (laminin 5) cicatricial pemphigoid complicated and exacerbated by herpes simplex virus type 2 infection. Australasian Journal of Dermatology 42(4): 271-274
Hsu, R.C.; Lazarova, Z.; Lee, H.G.; Tung, Y.C.; Yu, H.S. 2000: Antiepiligrin cicatricial pemphigoid. Journal of the American Academy of Dermatology 42(5 Pt 1): 841-844
Sakamoto, K.; Mori, K.; Hashimoto, T.; Yancey, K.B.; Nakashima, T. 2002: Antiepiligrin cicatricial pemphigoid of the larynx successfully treated with a combination of tetracycline and niacinamide. Archives of Otolaryngology--Head and Neck Surgery 128(12): 1420-1423
Lazarova, Z.; Hsu, R.; Yee, C.; Yancey, K.B. 1998: Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (alpha3beta3gamma2). British Journal of Dermatology 139(5): 791-797
Spencer, S.E.; McCarthy, N.; Hannigan, B.; Gill, D.; Taylor, M.R.; Murphy, D.; Walshe, J.J. 1996: Antiepithelial cell antibodies do not impair paediatric renal allograft survival but appear to be associated with acute viral infections. Transplant Immunology 4(1): 19-22
Makhaeva, G.F.; Iankovskaia, V.L.; Kovaleva, N.V.; Fetisov, V.I.; Malygin, V.V.; Torgasheva, N.A.; Khaskin, B.A. 1999: Antiesterase activity and toxicity of O,O-dialkyl-S-ethoxycarbonylbromomethylthiophosphates. Bioorganicheskaia Khimiia 25(1): 8-13
Ortega-Corona, B.G.; García-Bulnes, G.; Esparza-Avalos, N.; Ponce-Monter, H.; Valencia-Sánchez, A.; Villanueva-Tello, T.; Gallegos Cigarroa, A. 1993: Antiestrogen U23,469 induced alterations of catecholamine levels on plasma and central nervous system. Archives of Medical Research 24(1): 27-31
Watts, C.K.; Brady, A.; Sarcevic, B.; deFazio, A.; Musgrove, E.A.; Sutherland, R.L. 1995: Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Molecular Endocrinology 9(12): 1804-1813
Alba, E.; Ragonesi, G.; Colla, F.; Mazzoleni, A.; Farina, C. 2002: Antiestrogen therapy in the treatment of breast neoplasms. Minerva Ginecologica 54(3): 245-251
Sugimura, M.; Terao, T. 1994: Antiestrogen therapy of patients with uterine cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 52(3): 804-808
Smith, L.L.; White, I.N. 1998: Antiestrogen therapy: uncertainties and risk assessment. Oncology 12(3 Suppl 5: 14-22
Parker, M.G. 1996: Antiestrogen-estrogen receptor interactions. Cancer Treatment and Research 83: 213-224
Golob, T.; Biberger, C.; Walter, G.; von Angerer, E. 2000: Antiestrogenic activities of 3,8-dihydroxy-6,11-dihydrobenzo[a]carbazoles with sulfur-containing side chains. Archiv der Pharmazie 333(9): 305-311
Jin, L.; Borrás, M.; Lacroix, M.; Legros, N.; Leclercq, G. 1995: Antiestrogenic activity of two 11 beta-estradiol derivatives on MCF-7 breast cancer cells. Steroids 60(8): 512-518
Kimura, M. 2000: Antiestrogenic agents for treatment of advanced breast cancers. Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 311-316
Zacharewski, T.R.; Bondy, K.L.; McDonell, P.; Wu, Z.F. 1994: Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Cancer Research 54(10): 2707-2713
Faqi, A.S.; Chahoud, I. 1998: Antiestrogenic effects of low doses of 2,3,7,8-TCDD in offspring of female rats exposed throughout pregnancy and lactation. Bulletin of Environmental Contamination and Toxicology 61(4): 462-469
Jordan, V.C. 1996: Antiestrogens and the reduction in circulating cholesterol. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(8): 2407-2408
Marttunen, M.B.; Hietanen, P.; Tiitinen, A.; Viinikka, L.; Ylikorkala, O. 2000: Antiestrogens reduce plasma levels of endothelin-1 without affecting nitrate levels in breast cancer patients. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 14(1): 55-59
Borvendég, J.; Hermann, I.; Csuka, O. 1996: Antiestrogens, antiandrogens. Acta Physiologica Hungarica 84(4): 405-406
Välimäki, M.J.; Tiitinen, A. 1998: Antiestrogens--benefits of estrogens without their disadvantages?. Duodecim; Laaketieteellinen Aikakauskirja 114(19): 1885; 1887-1888
Jordan, V.C. 2000: Antiestrogens: clinical applications of pharmacology. Journal of the Society for Gynecologic Investigation 7(1 Suppl): S47-S48
Howell, A. 1997: Antiestrogens: future prospects. Oncology 11(2 Suppl 1: 59-64
Barrón-González, A.; Arias-Martínez, J.; Castro-Romero, I. 2001: Antiestrogens: mechanism of action and clinical applications. Salud Publica de Mexico 43(6): 577-584
Beaumont, J.L. 1993: Antiethinyl estradiol antibodies. Neurology 43(9): 1860-1861
Numbers, R.L.; Stenhouse, J. 2000: Antievolutionism in the Antipodes: from protesting evolution to promoting creationism in New Zealand. British Journal for the History of Science 33(118 Part 3): 335-350
Lévy, G. 1994: Antifactor VIIIc circulating anticoagulant. Annales Francaises d'Anesthesie et de Reanimation 13(1): 142-143
Kamakura, M.; Mitani, N.; Fukuda, T.; Fukushima, M. 2001: Antifatigue effect of fresh royal jelly in mice. Journal of Nutritional Science and Vitaminology 47(6): 394-401
Xue, B.; Liang, A.; Yang, Q.; Fu, M.; Wang, J. 1995: Antifebrile and anti-inflammatory effects of radix Cynanchi atrati. Zhongguo Zhong Yao Za Zhi 20(12): 751
Su, T.; Mulla, M.S. 1998: Antifeedancy of neem products containing Azadirachtin against Culex tarsalis and Culex quinquefasciatus (Diptera: Culicidae). Journal of Vector Ecology: Journal of the Society for Vector Ecology 23(2): 114-122
Vaccarini, C.E.; Palacios, S.M.; Meragelman, K.M.; Sosa, V.E. 2002: Antifeedant activity of metabolites from Viguiera tucumanensis. Natural Product Letters 16(5): 323-327
Martsev, S.P.; Kravchuk, Z.I.; Chumanevich, A.A.; Vlasov, A.P.; Dubnovitsky, A.P.; Bespalov, I.A.; Arosio, P.; Deyev, S.M. 1998: Antiferritin single-chain antibody: a functional protein with incomplete folding?. Febs Letters 441(3): 458-462
Munkholm, A.; Streiffer, S.K.; Ramana Murty, M.V.; Eastman, J.A.; Thompson, C.; Auciello, O.; Thompson, L.; Moore, J.F.; Stephenson, G.B. 2002: Antiferrodistortive reconstruction of the PbTiO(3)(001) surface. Physical Review Letters 88(1): 016101
Sigman, J.; Norton, D.P.; Christen, H.M.; Fleming, P.H.; Boatner, L.A. 2002: Antiferroelectric behavior in symmetric KNbO(3)/KTaO(3) superlattices. Physical Review Letters 88(9): 097601
Galerne; Liebert 1991: Antiferroelectric chiral smectic-O* liquid crystal. Physical Review Letters 66(22): 2891-2894
Giesselmann, F.; Lagerwall, J.P.F.; Andersson, G.; Radcliffe, M.D. 2002: Antiferroelectric liquid-crystal mixture without smectic layer shrinkage at the direct Sm-A*-Sm-C(*)(a) transition. Physical Review. E Statistical Nonlinear and Soft Matter Physics 66(5 Part 1): 051704
Brand, H.R.; Cladis, P.E.; Pleiner, H. 2001: Antiferroelectricity in liquid crystals. Physical Review Letters 86(21): 4974-4975
Krivnov; Ovchinnikov 1996: Antiferromagnet-ferromagnet transition in the one-dimensional frustrated spin model. Physical Review. B Condensed Matter 53(10): 6435-6441
Caneschi; Dei; Gatteschi; Sorace; Vostrikova 2000: Antiferromagnetic Coupling in a Gadolinium(III) Semiquinonato Complex. Angewandte Chemie 39(1): 246-248
Fabricius; Karbach; Löw; Mütter 1992: Antiferromagnetic Heisenberg model in a uniform external field. Physical Review. B Condensed Matter 45(10): 5315-5320
Tokihiro 1990: Antiferromagnetic Heisenberg model on a quasiperiodic lattice with hierarchical interactions. Physical Review. B Condensed Matter 41(10): 7334-7337
Gottlieb; Lagos; Hallberg; Balseiro 1991: Antiferromagnetic Heisenberg model with anisotropic coupling between nearest and next-nearest neighbors. Physical Review. B Condensed Matter 43(16): 13668-13671
Gómez-Santos 1992: Antiferromagnetic Heisenberg-Ising ring in the presence of a magnetic flux: Relevance of domain-wall dynamics. Physical Review. B Condensed Matter 45(10): 5339-5346
Schneider; Acet; Rellinghaus; Wassermann; Pepperhoff 1995: Antiferromagnetic Invar and anti-Invar in Fe-Mn alloys. Physical Review. B Condensed Matter 51(14): 8917-8921
Wang; Swendsen; Kotecký 1989: Antiferromagnetic Potts models. Physical Review Letters 63(2): 109-112
Ferreira; Sokal 1995: Antiferromagnetic Potts models on the square lattice. Physical Review. B Condensed Matter 51(10): 6727-6730
Psaltakis; Papanicolaou 1993: Antiferromagnetic and spiral phases in a t-t'-J model. Physical Review. B Condensed Matter 48(1): 456-472
Dagotto; Nazarenko; Moreo 1995: Antiferromagnetic and van Hove scenarios for the cuprates: Taking the best of both worlds. Physical Review Letters 74(2): 310-313
Kilibarda-Dalafave; Ng; Yuen; Lin; Crow; Tanner 1993: Antiferromagnetic conductivity mode in the modified Heusler alloy UNiSn. Physical Review. B Condensed Matter 48(1): 297-302
Millis; Monien 1992: Antiferromagnetic correlations and nuclear magnetic relaxation in high-Tc superconductors: a critical reexamination. Physical Review. B Condensed Matter 45(6): 3059-3076
Blinc; Pokhodnia; Cevc; Arcon; Omerzu; Mihailovic; Venturini; Golic; Trontelj; Luznik; Jeglicic; Pirnat 1996: Antiferromagnetic correlations and weak ferromagnetism in a TDAE+-C60 - single crystal. Physical Review Letters 76(3): 523-526
Gros; Joynt; Rice 1987: Antiferromagnetic correlations in almost-localized Fermi liquids. Physical Review. B Condensed Matter 36(1): 381-393
Kaga 1989: Antiferromagnetic correlations of heavy-fermion systems studied in the Zou-Anderson model with spin-orbit coupling. Physical Review. B Condensed Matter 39(13): 9296-9301
Kohmoto; Shapir 1988: Antiferromagnetic correlations of the resonating-valence-bond state. Physical Review. B Condensed Matter 37(16): 9439-9442
Le Dang K; Veillet; Chappert; Farrow; Marks; Weller; Cebollada 1994: Antiferromagnetic coupling in (111)-oriented Co/Pt superlattices. Physical Review. B Condensed Matter 50(1): 200-204
Egelhoff; Kief 1992: Antiferromagnetic coupling in Fe/Cu/Fe and Co/Cu/Co multilayers on Cu(111). Physical Review. B Condensed Matter 45(14): 7795-7804
Caneschi, A.; Dei, A.; Gatteschi, D.; Tangoulis, V. 2002: Antiferromagnetic coupling in a six-coordinate high spin cobalt(II)-semiquinonato complex. Inorganic Chemistry 41(13): 3508-3512
Papanicolaou 1995: Antiferromagnetic domain walls. Physical Review. B Condensed Matter 51(21): 15062-15073
Freitas; Melo; Trindade; From; Ferreira; Monteiro 1992: Antiferromagnetic exchange and magnetoresistance enhancement in Co-Re superlattices. Physical Review. B Condensed Matter 45(5): 2495-2498
Johnston 1996: Antiferromagnetic exchange in two-leg spin-1/2 ladders. Physical Review. B Condensed Matter 54(18): 13009-13016
Blumberg; Stojkovic; Klein 1995: Antiferromagnetic excitations and van Hove singularities in YBa2Cu3O6+x. Physical Review. B Condensed Matter 52(22): 15741-15744
Broholm; Aeppli; Espinosa; Cooper 1990: Antiferromagnetic fluctuations and short-range order in a Kagomé lattice. Physical Review Letters 65(25): 3173-3176
Moruzzi; Marcus 1992: Antiferromagnetic ground state of bcc chromium. Physical Review. B Condensed Matter 46(5): 3171-3174
Radtke; Liechtenstein; Yakovenko; Das Sarma S 1996: Antiferromagnetic interactions and the superconducting gap function. Physical Review. B Condensed Matter 53(9): 5137-5140
Borchers; Gehring; Erwin; Ankner; Majkrzak; Hylton; Coffey; Parker; Howard 1996: Antiferromagnetic interlayer correlations in annealed Ni80Fe20/Ag multilayers. Physical Review. B Condensed Matter 54(14): 9870-9882
Huber; Ching 1993: Antiferromagnetic magnons in diluted triangular and kagomé lattices. Physical Review. B Condensed Matter 47(6): 3220-3224
Zimanyi; Bedell 1993: Antiferromagnetic marginal Fermi liquid. Physical Review. B Condensed Matter 48(9): 6575-6587
Huang; Manousakis 1987: Antiferromagnetic order and high-temperature superconductivity. Physical Review. B Condensed Matter 36(16): 8302-8308
Goldman; Yang; Tranquada; Crow; Jee 1987: Antiferromagnetic order in DyBa2Cu. Physical Review. B Condensed Matter 36(13): 7234-7236
Goldman; Shirane; Aeppli; Batlogg; Bucher 1986: Antiferromagnetic order in U1-xThxPt3. Physical Review. B Condensed Matter 34(9): 6564-6566
Hayden; Taillefer; Vettier; Flouquet 1992: Antiferromagnetic order in UPt3 under pressure: Evidence for a direct coupling to superconductivity. Physical Review. B Condensed Matter 46(13): 8675-8678
Miceli; Tarascon; Greene; Barboux; Giroud; Neumann; Rhyne; Schneemeyer; Waszczak 1988: Antiferromagnetic order in YBa2Cu3-xCoxO6+y. Physical Review. B Condensed Matter 38(13): 9209-9212
Dumesnil; Dufour; Vergnat; Marchal; Mangin; Hennion; Lee; Kaiser; Rhyne 1994: Antiferromagnetic order in a Dy/Er superlattice. Physical Review. B Condensed Matter 49(17): 12274-12277
Tian 1994: Antiferromagnetic order in the periodic Anderson model at half filling: a rigorous result. Physical Review. B Condensed Matter 50(9): 6246-6249
Miyagawa; Kawamoto; Nakazawa; Kanoda 1995: Antiferromagnetic ordering and spin structure in the organic conductor, kappa -(BEDT-TTF)2Cu. Physical Review Letters 75(6): 1174-1177
Cebollada; Martnez; Gallego; de Miguel JJ; Miranda; Ferrer; Batallán; Fillion; Rebouillat 1989: Antiferromagnetic ordering in Co-Cu single-crystal superlattices. Physical Review. B Condensed Matter 39(13): 9726-9729
Sidis, Y.; Ulrich, C.; Bourges, P.; Bernhard, C.; Niedermayer, C.; Regnault, L.P.; Andersen, N.H.; Keimer, B. 2001: Antiferromagnetic ordering in superconducting YBa2Cu3O6.5. Physical Review Letters 86(18): 4100-4103
Yang; Ferreira; Lee; Maple; Li; Lynn; Erwin 1989: Antiferromagnetic ordering in superconducting and oxygen-deficient nonsuperconducting RBa2Cu3O7- delta compounds (R=Nd and Sm). Physical Review. B Condensed Matter 40(16): 10963-10972
Rosov; Lynn; Lin; Cao; O'Reilly; Pernambuco-Wise; Crow 1992: Antiferromagnetic ordering of BaPrO3 via neutron diffraction. Physical Review. B Condensed Matter 45(2): 982-986
Moudden; Shirane; Tranquada; Birgeneau; Endoh; Yamada; Hidaka; Murakami 1988: Antiferromagnetic ordering of Cu ions in NdBa2Cu. Physical Review. B Condensed Matter 38(13): 8720-8723
Wu; Freeman 1991: Antiferromagnetic ordering of Fe/Ru(0001). Physical Review. B Condensed Matter 44(9): 4449-4454
Bornemann; Walukiewicz; Bliss 1992: Antiferromagnetic ordering of defects in GaAs. Physical Review. B Condensed Matter 46(15): 9849-9852
Logan; Eastwood; Tusch 1996: Antiferromagnetic phase of the d=. Physical Review Letters 76(25): 4785-4788
Giebultowicz; Klosowski; Samarth; Luo; Rhyne; Furdyna 1990: Antiferromagnetic phase transition in Cd1-xMnxSe epilayers. Physical Review. B Condensed Matter 42(4): 2582-2585
Hu; Shi; Hua 1989: Antiferromagnetic phase transition in high-Tc superconductors. Physical Review. B Condensed Matter 40(16): 11306-11308
Caflisch 1986: Antiferromagnetic planar-rotator model under hn fields. Physical Review. B Condensed Matter 34(5): 3185-3191
Caflisch 1990: Antiferromagnetic planar-rotator model with further-neighbor interactions. Physical Review. B Condensed Matter 41(1): 432-438
Wei; Nie 1992: Antiferromagnetic polarization in the periodic Anderson lattice. Physical Review. B Condensed Matter 45(17): 10099-10102
Collins; Schlesinger; Shafer; McGuire 1988: Antiferromagnetic resonance in La2-x. Physical Review. B Condensed Matter 37(10): 5817-5819
Kaplan; Noh; Sievers; Cheong; Fisk 1989: Antiferromagnetic resonance in La2CuO4+y. Physical Review. B Condensed Matter 40(7): 5190-5193
Coulon; Scott; Laversanne 1986: Antiferromagnetic resonance in tetramethyltetrathiafulvalene (TMTTF) salts. Physical Review. B Condensed Matter 33(9): 6235-6242
Suzuki; Masuda; Tamaki 1988: Antiferromagnetic resonance of hyperfine-enhanced nuclear spins of 165Ho in Cs2NaHoCl6. Physical Review Letters 61(5): 633-636
Den Nijs M 1985: Antiferromagnetic restricted solid-on-solid model: Ising models on rough surfaces. Physical Review. B Condensed Matter 32(7): 4785-4788
Hirsch 1987: Antiferromagnetic singlet pairs, high-frequency phonons, and superconductivity. Physical Review. B Condensed Matter 35(16): 8726-8729
Thurston; Matsuda; Kakurai; Yamada; Endoh; Birgeneau; Gehring; Hidaka; Kastner; Murakami; Shirane 1990: Antiferromagnetic spin correlations in (Nd,Pr)2-xCexCuO4. Physical Review Letters 65(2): 263-266
Buyers; Kjems; Garrett 1985: Antiferromagnetic spin fluctuations in the heavy-fermion superconductor UPt3. Physical Review Letters 55(11): 1223-1226
Liu, W.V.; Fradkin, E. 2001: Antiferromagnetic spin ladders effectively coupled by one-dimensional electron liquids. Physical Review Letters 86(9): 1865-1868
Shelton; Nersesyan; Tsvelik 1996: Antiferromagnetic spin ladders: Crossover between spin S=1/2 and S=1 chains. Physical Review. B Condensed Matter 53(13): 8521-8532
Bose 1992: Antiferromagnetic spin models in two dimensions with known ground states. Physical Review. B Condensed Matter 45(22): 13072-13075
Wermbter; Tewordt 1991: Antiferromagnetic spin-fluctuation effects on quasiparticle damping and superconductivity in high-Tc materials. Physical Review. B Condensed Matter 43(13): 10530-10537
Loison; Diep 1994: Antiferromagnetic stacked triangular lattices with Heisenberg spins: Phase transition and effect of next-nearest-neighbor interaction. Physical Review. B Condensed Matter 50(22): 16453-16458
Blöte; Nightingale 1993: Antiferromagnetic triangular Ising model: Critical behavior of the ground state. Physical Review. B Condensed Matter 47(22): 15046-15059
Scalettar; Scalapino; Sugar; White 1991: Antiferromagnetic, charge-transfer, and pairing correlations in the three-band Hubbard model. Physical Review. B Condensed Matter 44(2): 770-781
Moruzzi; Marcus 1992: Antiferromagnetic-ferromagnetic transition in FeRh. Physical Review. B Condensed Matter 46(5): 2864-2873
Haas; Moreo; Dagotto 1995: Antiferromagnetically induced photoemission band in the cuprates. Physical Review Letters 74(21): 4281-4284
Chen, H-Dong.; Hu, J-Ping.; Capponi, S.; Arrigoni, E.; Zhang, S-Cheng. 2002: Antiferromagnetism and hole pair checkerboard in the vortex state of high T(c) superconductors. Physical Review Letters 89(13): 137004
Isaacs; Zschack; Broholm; Burns; Aeppli; Ramirez; Palstra; Erwin; Stücheli; Bucher 1995: Antiferromagnetism and its relation to the superconducting phases of UPt3. Physical Review Letters 75(6): 1178-1181
Freltoft; Remeika; Moncton; Cooper; Fischer; Harshman; Shirane; Sinha; Vaknin 1987: Antiferromagnetism and oxygen deficiency in single-crystal La2CuO4- delta. Physical Review. B Condensed Matter 36(1): 826-828
Takenobu; Muro; Iwasa; Mitani 2000: Antiferromagnetism and phase diagram in ammoniated alkali fulleride salts. Physical Review Letters 85(2): 381-384
Westerholt; Abs-Wurmbach; Dahlbeck 1986: Antiferromagnetism and spin-glass order in Fe-, Ca-, and Al-substituted braunites Mn2+(Mn3+)6SiO12. Physical Review. B Condensed Matter 34(9): 6437-6447
Chen; Su; Yu 1990: Antiferromagnetism and superconductivity in a two-dimensional Heisenberg model: Further studies on possible coexistence. Physical Review. B Condensed Matter 41(1): 267-272
Brewer; Ansaldo; Carolan; Chaklader; Hardy; Harshman; Hayden; Ishikawa; Kaplan; Keitel; Kempton; Kiefl; Kossler; Kreitzman; Kulpa; Kuno; Luke; Miyatake; Nagamine; Nakazawa; Nishida; Nishiyama; Ohkuma; Riseman; Roehmer; Schleger; Shimada; Stronach; Takabatake; Uemura; Watanabe; Williams; Yamazaki; Yang 1988: Antiferromagnetism and superconductivity in oxygen-deficient YBa2Cu. Physical Review Letters 60(11): 1073-1076
Kuno; Nishida; Miyatake; Okuma; Watanabe; Yamazaki; Ishikawa; Takabatake; Nakazawa; Brewer; Kreitzman; Riseman 1988: Antiferromagnetism and superconductivity in the presence of Ho moments in HoBa2Cu3Ox. Physical Review. B Condensed Matter 38(13): 9276-9279
Herbut, I.F. 2002: Antiferromagnetism from phase disordering of a d-wave superconductor. Physical Review Letters 88(4): 047006
Vaknin; Caignol; Davies; Fischer; Johnston; Goshorn 1989: Antiferromagnetism in (Ca0.85Sr0.15)CuO2, the parent of the cuprate family of superconducting compounds. Physical Review. B Condensed Matter 39(13): 9122-9125
Moruzzi; Marcus 1990: Antiferromagnetism in 3d transition metals. Physical Review. B Condensed Matter 42(13): 8361-8366
Moruzzi; Marcus 1990: Antiferromagnetism in 4d transition metals. Physical Review. B Condensed Matter 42(16): 10322-10328
Garde; Ray; Chandra 1991: Antiferromagnetism in Ce1-xLaxAl2Ga2 and Ce1-yYyAl2Ga2 Kondo-lattice systems. Physical Review. B Condensed Matter 43(4): 3204-3207
Vaknin; Sinha; Moncton; Johnston; Newsam; Safinya; King 1987: Antiferromagnetism in La2CuO. Physical Review Letters 58(26): 2802-2805
Vaknin; Sinha; Stassis; Miller; Johnston 1990: Antiferromagnetism in Sr2CuO2Cl2. Physical Review. B Condensed Matter 41(4): 1926-1933
Tranquada; Moudden; Goldman; Zolliker; Cox; Shirane; Sinha; Vaknin; Johnston; Alvarez; Jacobson; Lewandowski; Newsam 1988: Antiferromagnetism in YBa2Cu. Physical Review. B Condensed Matter 38(4): 2477-2485
Zhang; Bennemann 1992: Antiferromagnetism in electron- and hole-doped high-Tc superconductors. Physical Review. B Condensed Matter 45(21): 12487-12491
Goniakowski; Podgórny 1991: Antiferromagnetism in hexagonal chromium, manganese, and iron. Physical Review. B Condensed Matter 44(22): 12348-12352
Ramakrishnan; Ghosh; Chandra 1992: Antiferromagnetism in the Dy5Ir4Si10 system. Physical Review. B Condensed Matter 45(18): 10769-10770
Jonason; Ghosh; Ramakrishnan; Chandra 1994: Antiferromagnetism in the Ho5Os4Ge10 system. Physical Review. B Condensed Matter 50(10): 7169-7172
Hirsch; Tang 1989: Antiferromagnetism in the two-dimensional Hubbard model. Physical Review Letters 62(5): 591-594
Song; Shen 1993: Antiferromagnetism in the two-dimensional infinite-U Hubbard model. Physical Review. B Condensed Matter 47(21): 14576-14579
Dutka; Oles 1991: Antiferromagnetism in three-band Hubbard model: Local-ansatz approach. Physical Review. B Condensed Matter 43(7): 5622-5633
Weinert; Fernando 1989: Antiferromagnetism of CuO2 layers. Physical Review. B Condensed Matter 39(1): 835-838
Arrigoni; Strinati; Castellani 1990: Antiferromagnetism of CuO2 layers within a slave-boson approach. Physical Review. B Condensed Matter 41(7): 4838-4841
Uemura; Kossler; Yu; Kempton; Schone; Opie; Stronach; Johnston; Alvarez; Goshorn 1987: Antiferromagnetism of La2CuO. Physical Review Letters 59(9): 1045-1048
Hirsch 1987: Antiferromagnetism, localization, and pairing in a two-dimensional model for CuO2. Physical Review Letters 59(2): 228-231
Oja; Viertiö 1993: Antiferromagnets with anisotropic spin-spin interactions: Stability of the zero-field structure in an external field. Physical Review. B Condensed Matter 47(1): 237-253
Birgeneau; Gabbe; Jenssen; Kastner; Picone; Thurston; Shirane; Endoh; Sato; Yamada; Hidaka; Oda; Enomoto; Suzuki; Murakami 1988: Antiferromangetic spin correlations in insulating, metallic, and superconducting La2-xSrx. Physical Review. B Condensed Matter 38(10): 6614-6623
Sun, X.; Li, D.; Li, C. 1998: Antifertile effect of immunization with anti-idiotypic antibodies to porcine zona pellucida. Zhonghua Yi Xue Za Zhi 78(11): 856-858
Badami, S.; Aneesh, R.; Sankar, S.; Sathishkumar, M.N.; Suresh, B.; Rajan, S. 2003: Antifertility activity of Derris brevipes variety coriacea. Journal of Ethnopharmacology 84(1): 99-104
Makonnen, E.; Zerihun, L.; Assefa, G.; Rostom, A.A. 1999: Antifertility activity of Ricinus communis seed in female guinea pigs. East African Medical Journal 76(6): 335-337
Ray, S.; Grover, P.K.; Anand, N. 1970: Antifertility agents: 5. Synthesis of 2,2-dimethyl-3,4-diphenyl-5,6-benzochromenes and 1,1-dimethyl-2,3-diphenylphenalenes. Indian Journal of Chemistry 8(11): 961-963
Fraser, H.M. 1983: Antifertility and therapeutic effects of GnRH. Contraception Fertilite Sexualite 11(4): 609-624
Azimahtol Hawariah Lope Pihie; Embun Naim 1983: Antifertility effect of Jamu (traditional herbal medicine). Malaysian Journal of Reproductive Health: a Publication of the Reproductive Research Centre of the National Population and Family Development Board Malaysia 1(2): 176-180
Tewari, P.V.; Chaturvedi, C.; Dixit, S.N. 1970: Antifertility effect of betal leaf stalk (Tambul patrabrint): a preliminary experimental study. Journal of Research in Indian Medicine 4(2): 143-151
Santra, K.B.; Manna, C.K. 2002: Antifertility effects of methylmethane sulphonate on male reproductive organs of wild Indian house rat: histological and histochemical characteristics. Endocrine Regulations 36(3): 123-131
Xian, S.C.; Wu, Z.E.; Wuhan Tsong, S.D.; Tung, D.S. 1987: Antifertility treating with long term gossypol. Advances in Contraceptive Delivery Systems: Cds 3(2-3): 181
Wang, Y.F. 1982: Antifertility vaccine research--present status and prospects. Sheng Zhi Yu Bi Yun 2(3): 3-7
Benfey, B.G. 1993: Antifibrillatory effects of alpha 1-adrenoceptor blocking drugs in experimental coronary artery occlusion and reperfusion. Canadian Journal of Physiology and Pharmacology 71(2): 103-111
Adamson, P.B.; Vanoli, E.; Hull, S.S.; Foreman, R.D.; Schwartz, P.J. 1998: Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. Cardiovascular Research 40(1): 56-63
Galanakis, D.K.; Henschen-Edman, A.; Weisel, J.; Spitzer, S. 2001: Antifibrinogen IgG, fibrinogen, and Clq complexes circulating in a hypodysfibrinogenemic proband. Isolation, stoichiometry, and partial characterization. Annals of the new York Academy of Sciences 936: 611-616
Smith, M.S. 1999: Antifibrinolytic agents make alpha1- and beta2-microglobulinuria poor markers of postcardiac surgery renal dysfunction. Anesthesiology 90(3): 928-929
Parker, B.M.; Irefin, S.A. 2001: Antifibrinolytic therapy and pulmonary thromboembolism during orthotopic liver transplantation. Anesthesia and Analgesia 92(2): 559-560
Donias, H.W.; Karamanoukian, R.L.; Karamanoukian, H.L. 2002: Antifibrinolytic therapy during OPCAB surgery: a word of caution. Journal of Cardiothoracic and Vascular Anesthesia 16(3): 391-392
Kaufman, B.; Wise, A. 1993: Antifibrinolytic therapy for haemoptysis related to bronchial carcinoma. Postgraduate Medical Journal 69(807): 80
Matsuzaki, K.; Matsui, K.; Tanoue, Y.; Nagano, I.; Haraguchi, N.; Tatewaki, H. 1999: Antifibrinolytic therapy with tranexamic acid in cardiac operations. Cardiovascular Surgery 7(2): 195-199
Horrow, J.C. 1995: Antifibrinolytic therapy: treat whom and with what?. Journal of Clinical Anesthesia 7(8): 690
Medina Pérez, A.; De las Nieves, M.A. 1999: Antifibrinolytics as a treatment for severe factor Xi deficiency in laryngeal surgery. Sangre 44(3): 246-247
Kufner, R.P. 1997: Antifibrinolytics do not reduce transfusion requirements in patients undergoing orthotopic liver transplantation. Liver Transplantation and Surgery: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 3(6): 668-674; Discussion: 674-676
Cooke, I.; Lethaby, A.; Farquhar, C. 2000: Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2: Cd000249
Ronda, N.; Gatti, R.; Giacosa, R.; Raschi, E.; Testoni, C.; Meroni, P.Luigi.; Buzio, C.; Orlandini, G. 2002: Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway. Arthritis and Rheumatism 46(6): 1595-1601
Suou, T. 1999: Antifibrogenic activity of interferon alpha in chronic hepatitis C. Journal of Gastroenterology 34(3): 426-427
Yasuda, H.; Imai, E.; Shiota, A.; Fujise, N.; Morinaga, T.; Higashio, K. 1996: Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24(3): 636-642
Shimizu, I. 2001: Antifibrogenic therapies in chronic HCV infection. Current Drug Targets. Infectious Disorders 1(2): 227-240
Sánchez-Pernaute, O.; López-Armada, M.J.; Hernández, P.; Palacios, I.; Navarro, F.; Martínez, J.; Egido, J.; Herrero-Beaumont, G. 1997: Antifibroproliferative effect of tenidap in chronic antigen-induced arthritis. Arthritis and Rheumatism 40(12): 2147-2156
Giri, S.N.; Hyde, D.M.; Braun, R.K.; Gaarde, W.; Harper, J.R.; Pierschbacher, M.D. 1997: Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochemical Pharmacology 54(11): 1205-1216
Brilla, C.G.; Matsubara, L.S.; Weber, K.T. 1993: Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. American Journal of Cardiology 71(3): 12A-16A
Rewald, E. 1999: Antifibrotic tendency as complement to inflammatory burnout? Six year IVIG treatment in a case with atherosclerosis and chronic hepatitis C. Transfusion Science 21(1): 3-5
Singh, R.; Singhal, K.C.; Khan, N.U. 1997: Antifilarial activity of Mallotus philippensis Lam. on Setaria cervie (Nematoda: Filarioidea) in vitro. Indian Journal of Physiology and Pharmacology 41(4): 397-403
Mize, N.K.; Buttery, M.; Ruis, N.; Leung, I.; Cormier, M.; Daddona, P. 1997: Antiflammin 1 peptide delivered non-invasively by iontophoresis reduces irritant-induced inflammation in vivo. Experimental Dermatology 6(4): 181-185
Moreno, J.J. 2000: Antiflammin peptides in the regulation of inflammatory response. Annals of the new York Academy of Sciences 923: 147-153
Miele, L. 2000: Antiflammins. Bioactive peptides derived from uteroglobin. Annals of the new York Academy of Sciences 923: 128-140
Chung; Ajitanand; Alexander; Anderson; Best; Brady; Case; Caskey; Cebra; Chance; Cole; Crowe; Das; Draper; Gilkes; Gushue; Heffner; Hirsch; Hjort; Huo; Justice; Kaplan; Keane; Kintner; Klay; Krofcheck 2000: Antiflow of K(0)(s) mesons in 6A GeV au + au collisions. Physical Review Letters 85(5): 940-943
Hall, G.H. 2001: Antiflu, or antideath vaccination?. Lancet 357(9274): 2141
Lowry, R.J. 2000: Antifluoridation propaganda material--the tricks of the trade. British Dental Journal 189(10): 528-530
Lauterbach, B.; Kakkassery, V.; Debus, D.; Heindl, L.M.; Schultz, E.S. 2019: Advanced periocular basal cell carcinoma-a therapeutic challenge. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 116(3): 273-277
Takemura, Y.; Kobayashi, H.; Miyachi, H. 2001: Antifolate resistance and its circumvention by new analogues. Human Cell 14(3): 185-202
Cortese, J.F.; Plowe, C.V. 1998: Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Molecular and Biochemical Parasitology 94(2): 205-214
Ouellette, M.; Leblanc, E.; Kündig, C.; Papadopoulou, B. 1998: Antifolate resistance mechanisms from bacteria to cancer cells with emphasis on parasites. Advances in Experimental Medicine and Biology 456: 99-113
Sirawaraporn, W.; Sathitkul, T.; Sirawaraporn, R.; Yuthavong, Y.; Santi, D.V. 1997: Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proceedings of the National Academy of Sciences of the United States of America 94(4): 1124-1129
Takimoto, C.H. 1997: Antifolates in clinical development. Seminars in Oncology 24(5 Suppl 18: S18
Baggott, J.E.; Morgan, S.L.; Ha, T.S.; Alarcón, G.S.; Koopman, W.J.; Krumdieck, C.L. 1993: Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clinical and Experimental Rheumatology 11(Suppl 8): S101-S105
Rayl, E.A.; Pizzorno, G. 1996: Antifolates: current developments. Cancer Treatment and Research 87: 197-223
Haynes, D.; Loong, D. 2002: Antifoulant (butyltin and copper) concentrations in sediments from the Great Barrier Reef World Heritage Area, Australia. Environmental Pollution 120(2): 391-396
Devi; Vennam; Naik; Parameshwaran; Raveendran; Yeshwant 1998: Antifouling activity of Indian marine invertebrates against the green mussel Perna viridis L. Journal of Marine Biotechnology 6(4): 229-232
Shin, H.W.; Smith, C.M. 2001: Antifouling activity of six nontoxic chemicals on spore attachment of Ulva fasciata. Journal of Environmental Biology 22(3): 145-151
Thomasma, D.C. 1997: Antifoundationalism and the possibility of a moral philosophy of medicine. Theoretical Medicine 18(1-2): 127-143
Abruzzo, M.D. 1999: Antifraud push means plans need to focus on compliance. Managed Care 8(6): 25-26
Yeh, Y.; Feeney, R.E.. 1996: Antifreeze Proteins: Structures and Mechanisms of Function. Chemical Reviews 96(2): 601-618
Wöhrmann, A. 1996: Antifreeze glycoproteins in fishes: structure, mode of action and possible applications. Tierarztliche Praxis 24(1): 1-9
Ben, R.N. 2001: Antifreeze glycoproteins--preventing the growth of ice. Chembiochem: a European Journal of Chemical Biology 2(3): 161-166
Davies, P.L.; Sykes, B.D. 1997: Antifreeze proteins. Current Opinion in Structural Biology 7(6): 828-834
Leal-Klevezas, D.S.; Martínez-Vázquez, I.O.; Cuevas-Hernández, B.; Martínez-Soriano, J.P. 2000: Antifreeze solution improves DNA recovery by preserving the integrity of pathogen-infected blood and other tissues. Clinical and Diagnostic Laboratory Immunology 7(6): 945-946
Van Delden, C.; Lew, D.P..; Chapuis, B.; Rohner, P.; Hirschel, B. 1995: Antifungal Prophylaxis in Severely Neutropenic Patients: how Much Fluconazole is Necessary?. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 1(1): 24-30
Manohar, V.; Ingram, C.; Gray, J.; Talpur, N.A.; Echard, B.W.; Bagchi, D.; Preuss, H.G. 2001: Antifungal activities of origanum oil against Candida albicans. Molecular and Cellular Biochemistry 228(1-2): 111-117
Bhat, J.M.; Narayanan, M.S. 1996: Antifungal activity (invitro) of certain polyene macrolide antibiotics against various plant pathogens. Hindustan Antibiotics Bulletin 38(1-4): 32-36
Rana, B.K.; Singh, U.P.; Taneja, V. 1997: Antifungal activity and kinetics of inhibition by essential oil isolated from leaves of Aegle marmelos. Journal of Ethnopharmacology 57(1): 29-34
Romagnoli, C.; Mares, D.; Bruni, A.; Andreotti, E.; Manfrini, M.; Vicentini, C.B. 2002: Antifungal activity of 5 new synthetic compounds vs. Trichophyton rubrum and Epidermophyton floccosum. Mycopathologia 153(3): 129-132
Mastrolorenzo, A.; Scozzafava, A.; Supuran, C.T. 2000: Antifungal activity of Ag(I) and Zn(II) complexes of aminobenzolamide (5-sulfanilylamido-1,3,4-thiadiazole-2-sulfonamide) derivatives. Journal of Enzyme Inhibition 15(6): 517-531
Cafarchia, C.; De Laurentis, N.; Milillo, M.A.; Losacco, V.; Puccini, V. 1999: Antifungal activity of Apulia region propolis. Parassitologia 41(4): 587-590
Czaczyk, K.; Stachowiak, B.; Trojanowska, K.; Gulewicz, K. 2000: Antifungal activity of Bacillus sp. isolated from compost. Folia Microbiologica 45(6): 552-554
Wuthi-udomlert, M.; Grisanapan, W.; Luanratana, O.; Caichompoo, W. 2000: Antifungal activity of Curcuma longa grown in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 31(Suppl 1): 178-182
Dutta, B.K.; Rahman, I.; Das, T.K. 1998: Antifungal activity of Indian plant extracts. Mycoses 41(11-12): 535-536
Marco, F.; Pfaller, M.A.; Messer, S.A.; Jones, R.N. 1998: Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Medical Mycology 36(6): 433-436
Maesaki, S.; Iwakawa, J.; Higashiyama, Y.; Miyazaki, Y.; Yanagihara, K.; Tomono, K.; Tashiro, T.; Kohno, S. 2000: Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 6(2): 101-103
Karavaev, V.A.; Solntsev, M.K.; Iurina, T.P.; Iurina, E.V.; Poliakova, I.B.; Kuznetsov, A.M. 2001: Antifungal activity of aqueous extracts from the leaf of cowparsnip and comfrey. Izvestiia Akademii Nauk. Seriia Biologicheskaia 4: 435-441
Singh, Y.; Chaurasia, L.; Nayal, S.S. 2000: Antifungal activity of bicyclic heterocyclic-1,2-diazole. Indian Journal of Experimental Biology 38(5): 516-518
Pizzo, G.; Giuliana, G. 1998: Antifungal activity of chlorhexidine containing mouthrinses. An in vitro study. Minerva Stomatologica 47(12): 665-671
Pawlik, B.; Macura, A.B. 1995: Antifungal activity of fluconazole in vitro. Medycyna Doswiadczalna i Mikrobiologia 47(1-2): 101-106
Ali-Shtayeh, M.S.; Abu Ghdeib, S.I. 1999: Antifungal activity of plant extracts against dermatophytes. Mycoses 42(11-12): 665-672
Ota, C.; Unterkircher, C.; Fantinato, V.; Shimizu, M.T. 2001: Antifungal activity of propolis on different species of Candida. Mycoses 44(9-10): 375-378
Bhosale, S.H.; Jagtap, T.G.; Naik, C.G. 1999: Antifungal activity of some marine organisms from India, against food spoilage Aspergillus strains. Mycopathologia 147(3): 133-138
Vashishtha, S.C.; Dimmock, J.R.; Manavathu, E.K. 1998: Antifungal activity of some quaternary ammonium salts of 4-(2-arylvinyl)-3-(3-aryl-2-propenoyl)-1-ethyl-4-piperidinols and related compounds. Die Pharmazie 53(7): 499-500
Arévalo, M.ía.P.; Carrillo-Muñoz, A.-J.; Salgado, J.; Cardenes, D.; Brió, S.; Quindós, G.; Espinel-Ingroff, A. 2003: Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method. Journal of Antimicrobial ChemoTherapy 51(1): 163-166
Shin, S.; Kang, C.-A. 2003: Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazole. Letters in Applied Microbiology 36(2): 111-115
Kappe, R. 2001: Antifungal activity of the new azole UK-109 496 (voriconazole): addition and clarification. Mycoses 44(9-10): 432
Kappe, R. 1999: Antifungal activity of the new azole UK-109, 496 (voriconazole). Mycoses 42(Suppl 2): 83-86
Singh, U.P.; Sarma, B.K.; Mishra, P.K.; Ray, A.B. 2000: Antifungal activity of venenatine, an indole alkaloid isolated from Alstonia venenata. Folia Microbiologica 45(2): 173-176
Odds, F.C. 1995: Antifungal agent resistance of yeasts of clinical significance. Revista Clinica Espanola 195(Suppl 3): 56-57
Carruth, A.K. 1993: Antifungal agent used topically to control odor. Oncology Nursing Forum 20(8): 1262
Levin, R.H.; Wong, A.F. 1994: Antifungal agents and their renal implications in the neonate. Journal of Perinatal and Neonatal Nursing 8(1): 59-73
Petrini, B.ör.; Chryssanthou, E. 2002: Antifungal agents can change the balance between resistant and susceptible Candida species. Lakartidningen 99(20): 2293-2294
Massa, S.; Ragno, R.; Porretta, G.C.; Mai, A.; Retico, A.; Artico, M.; Simonetti, N. 1993: Antifungal agents, II: Synthesis and antifungal activities of aryl-1H-pyrrol-2-yl-1H-imidazol-1-yl-methane derivatives with unsaturated chains. Archiv der Pharmazie 326(9): 539-546
Tafi, A.; Costi, R.; Botta, M.; Di Santo, R.; Corelli, F.; Massa, S.; Ciacci, A.; Manetti, F.; Artico, M. 2002: Antifungal agents. 10. new derivatives of 1-[(aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-candida activity, and quantitative structure-analysis relationship studies. Journal of Medicinal Chemistry 45(13): 2720-2732
Coleman, S.G.; Brooke, G. 1999: Antifungal agents. Summary and table. Drugs in R&d 1(2): 161-164
Stefancich, G.; Silvestri, R.; Pagnozzi, E.; Artico, M.; Retico, A.; Apuzzo, G.; Simonetti, N. 1993: Antifungal agents. VI. in vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols. Farmaco 48(8): 1103-1112
Zhao, W.; Wolfender, J.L.; Hostettmann, K.; Xu, R.; Qin, G. 1998: Antifungal alkaloids and limonoid derivatives from Dictamnus dasycarpus. Phytochemistry 47(1): 7-11
Clark, R.J.; Garson, M.J.; Hooper, J.N. 2001: Antifungal alkyl amino alcohols from the tropical marine sponge Haliclona n. sp. Journal of Natural Products 64(12): 1568-1571
Blease, K.; Mehrad, B.; Lukacs, N.W.; Kunkel, S.L.; Standiford, T.J.; Hogaboam, C.M. 2001: Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. Journal of Immunology 166(3): 1832-1842
Gafner, S.; Wolfender, J.L.; Nianga, M.; Stoeckli-Evans, H.; Hostettmann, K. 1996: Antifungal and antibacterial naphthoquinones from Newbouldia laevis roots. Phytochemistry 42(5): 1315-1320
Pallasch, T.J. 2002: Antifungal and antiviral chemotherapy. Periodontology 2000 28: 240-255
Dhuley, J.N. 1998: Antifungal antibiotic hamycin increases susceptibility of Candida albicans to phagocytosis by murine macrophages. Fems Immunology and Medical Microbiology 20(2): 153-157
Navashin, P.S. 1998: Antifungal chemotherapy. Progress and problems. Antibiotiki i Khimioterapiia 43(8): 3-6
Graybill, J.R.; Tollemar, J.; Torres-Rodríguez, J.M.; Walsh, T.J.; Roilides, E.; Farmaki, E. 2000: Antifungal compounds: controversies, queries and conclusions. Medical Mycology 38(Suppl 1): 323-333
Vanden Bossche, H.; Dromer, F.; Improvisi, I.; Lozano-Chiu, M.; Rex, J.H.; Sanglard, D. 1998: Antifungal drug resistance in pathogenic fungi. Medical Mycology 36(Suppl 1): 119-128
Rogers, T.R. 2002: Antifungal drug resistance: does it matter?. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 6(Suppl 1): S47-S53
Rogers, T.R.; Barnes, R.A.; Denning, D.W.; Evans, E.G.; Hay, R.J.; Prentice, A.G.; Speller, D.C.; Warnock, D.W.; Warren, R.E. 1995: Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy. Journal of Antimicrobial ChemoTherapy 36(6): 899-909
Goldman, R.C.; Frost, D.J.; Capobianco, J.O.; Kadam, S.; Rasmussen, R.R.; Abad-Zapatero, C. 1995: Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis. Infectious Agents and Disease 4(4): 228-247
Wynn, R.L.; Jabra-Rizk, M.A.; Meiller, T.F. 1999: Antifungal drugs and fungal resistance: the need for a new generation of drugs. General Dentistry 47(4): 352-355
Graybill, J.R. 1995: Antifungal drugs and resistance. Advances in Experimental Medicine and Biology 390: 217-234
Chimenos, E..; Puy, D..; Lopez, J.. 1998: Antifungal drugs in the management of mycosis. Medicina Oral: Organo Oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal 3(2): 78-90
Datry, A.; Thellier, M.; Traoré, B.; Alfa Cissé, O.; Danis, M. 2001: Antifungal drugs in the treatment of systemic candidiasis: susceptibility to antifungal drugs, drug resistance, pharmacological data. Annales Francaises d'Anesthesie et de Reanimation 20(4): 389-393
Baquero, F. 1998: Antifungal drugs: the new frontier. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 11(3): 187-188
Wang, L.D.; Guo, D.A.; Yuan, L.; He, Q.H.; Hu, Y.Q.; Tu, P.F.; Zheng, J.H. 2000: Antifungal effect of three natural products on the genetic substance of Saccharomyces cerevisiae GL7 and Prototheca wickerhamii. Yao Xue Xue Bao 35(11): 860-863
Pandit, R.T. 2003: Antifungal effects of cyclosporine a. Cornea 22(1): 92-93
Siqueira, J.F.; Rôças, I.N.; Magalhães, F.A.; de Uzeda, M. 2001: Antifungal effects of endodontic medicaments. Australian Endodontic Journal: the Journal of the Australian Society of Endodontology Inc 27(3): 112-114
Nesmĕrák, K.; Pelouchová, H.; Vsetecka, V.; Nĕmec, I.; Gabriel, J. 1998: Antifungal effects of new heterocyclic compounds, 6H-pyrimido[2,1-a]isoindole derivatives. Folia Microbiologica 43(1): 39-41
Sen, B.H.; Safavi, K.E.; Spångberg, L.S. 1999: Antifungal effects of sodium hypochlorite and chlorhexidine in root canals. Journal of Endodontics 25(4): 235-238
Peters, B.G.; Adkins, D.R.; Harrison, B.R.; Velasquez, W.S.; Dunphy, F.R.; Petruska, P.J.; Bowers, C.E.; Niemeyer, R.; McIntyre, W.; Vrahnos, D.; Auberry, S.E.; Spitzer, G. 1996: Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis. Bone Marrow Transplantation 18(1): 93-102
Petraitiene, R.; Petraitis, V.; Groll, A.H.; Sein, T.; Schaufele, R.L.; Francesconi, A.; Bacher, J.; Avila, N.A.; Walsh, T.J. 2002: Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrobial Agents and ChemoTherapy 46(1): 12-23
Talley, S.M.; Coley, P.D.; Kursar, T.A. 2002: Antifungal leaf-surface metabolites correlate with fungal abundance in sagebrush populations. Journal of Chemical Ecology 28(11): 2141-2168
Wicklow, D.T.; Joshi, B.K.; Gamble, W.R.; Gloer, J.B.; Dowd, P.F. 1998: Antifungal metabolites (monorden, monocillin IV, and cerebrosides) from Humicola fuscoatra traaen NRRL 22980, a mycoparasite of Aspergillus flavus sclerotia. Applied and Environmental Microbiology 64(11): 4482-4484
Ghisalberti, E.L.; Rowland, C.Y. 1993: Antifungal metabolites from Trichoderma harzianum. Journal of Natural Products 56(10): 1799-1804
Kleitz, S.; Grimoud, A.M. 1999: Antifungal mouthwashes: protocol for care. Revue de l'Infirmiere 45: 53-55
De Lucca, A.J.; Walsh, T.J. 1999: Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrobial Agents and ChemoTherapy 43(1): 1-11
De Lucca, A.J. 2000: Antifungal peptides: potential candidates for the treatment of fungal infections. Expert Opinion on Investigational Drugs 9(2): 273-299
Gallagher, J.C.; Dodds Ashley, E.S.; Drew, R.H.; Perfect, J.R. 2003: Antifungal pharmacotherapy for invasive mould infections. Expert Opinion on PharmacoTherapy 4(2): 147-164
Brown, C.N.; Hulick, P.R. 1996: Antifungal powder helps to reduce skin reactions. Oncology Nursing Forum 23(9): 1483
Kinsman, O.S.; Livermore, D.G.; Smith, C. 1993: Antifungal properties in a novel series of triazino[5,6-b]indoles. Antimicrobial Agents and ChemoTherapy 37(6): 1243-1246
Dubey, N.K.; Tiwari, T.N.; Mandin, D.; Andriamboavonjy, H.; Chaumont, J.P. 2000: Antifungal properties of Ocimum gratissimum essential oil (ethyl cinnamate chemotype). Fitoterapia 71(5): 567-569
Nesmĕrák, K.; Pospísek, M.; Nĕmec, I.; Waisser, K.; Gabriel, J. 2000: Antifungal properties of substituted 1-phenyl-5-mercaptotetrazoles and their oxidation product, 5-bis-(1-phenyltetrazolyl)disulfide. Folia Microbiologica 45(2): 138-142
Bodey, G.P.; Anaissie, E.J.; Elting, L.S.; Estey, E.; O'Brien, S.; Kantarjian, H. 1994: Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B. Cancer 73(8): 2099-2106
Calvo, V.; Borro, J.M.; Morales, P.; Morcillo, A.; Vicente, R.; Tarrazona, V.; París, F. 1999: Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest 115(5): 1301-1304
Wadhwa, N.K.; Suh, H.; Cabralda, T. 1996: Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 12: 189-191
Marr, K.A. 2001: Antifungal prophylaxis in hematopoietic stem cell transplant recipients. Oncology 15(11 Suppl 9: 15-19
Biancofiore, G.; Bindi, M.L.; Baldassarri, R.; Romanelli, A.M.; Catalano, G.; Filipponi, F.; Vagelli, A.; Mosca, F. 2002: Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transplant International: Official Journal of the European Society for Organ Transplantation 15(7): 341-347
Cornely, O.A.; Ullmann, A.J.; Karthaus, M. 2001: Antifungal prophylaxis in neutropenic patients. Wiener Medizinische Wochenschrift 151(3-4): 73-79
Kibbler, C.C. 1999: Antifungal prophylaxis with itraconazole oral solution in neutropenic patients. Mycoses 42(Suppl 2): 121-124
Goranov, S.; Spasov, E.; Grudeva-Popova, J.; Vakrilov, V. 1999: Antifungal prophylaxis with low doses fluconazole in patients with hematological malignancies. Folia Medica 41(4): 68-72
Mylonakis, E.; Flanigan, T.P. 1998: Antifungal prophylaxis with weekly fluconazole for patients with AIDS. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 27(6): 1376-1378
Smith, G.N. 1996: Antifungal pulse therapy for onychomycosis. Journal of Family Practice 42(4): 348
Collin, B.; Clancy, C.J..; Nguyen, M.. H. 1999: Antifungal resistance in non- albicans Candida species. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer ChemoTherapy 2(1): 9-14
Martínez-Suárez, J.V.; Rodríguez-Tudela, J.L. 1996: Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine. Enfermedades Infecciosas y Microbiologia Clinica 14(6): 384-389
Martínez-Suárez, J.V.; Rodríguez-Tudela, J.L. 1996: Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles. Enfermedades Infecciosas y Microbiologia Clinica 14(8): 490-498
Dun, E. 1999: Antifungal resistance in yeast vaginitis. Yale Journal of Biology and Medicine 72(4): 281-285
McCutcheon, A.R.; Ellis, S.M.; Hancock, R.E.; Towers, G.H. 1994: Antifungal screening of medicinal plants of British Columbian native peoples. Journal of Ethnopharmacology 44(3): 157-169
Wolf, R.; Wolf, D.; Ruocco, V. 1999: Antifungal sponsored supplements. Journal of the American Academy of Dermatology 40(2 Pt 1): 282
Guo, D.A.; Mangla, A.T.; Zhou, W.; Lopez, M.; Jia, Z.; Nichols, S.D.; Nes, W.D. 1997: Antifungal sterol biosynthesis inhibitors. Sub-Cellular Biochemistry 28: 89-116
Bradley, M.C.; Leidich, S.; Isham, N.; Elewski, B.E.; Ghannoum, M.A. 1999: Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 42(Suppl 2): 105-110
Hill, P.C.; Rogers, K.; McKinney, W.P.; Morris, A.J.; Holland, D.J. 2001: Antifungal susceptibilities of Candida sp. in New Zealand. New Zealand Medical Journal 114(1144): 528-529
Kovacicova, G.; Krupova, Y.; Lovaszova, M.; Roidova, A.; Trupl, J.; Liskova, A.; Hanzen, J.; Milosovic, P.; Lamosova, M.; Macekova, L.; Szovenyiova, Z.; Purgelova, A.; Obertik, T.; Bille, J.; Krcmery, V. 2000: Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 6(4): 216-221
Voigt, W. 2018: Advanced PET imaging in oncology: status and developments with current and future relevance to lung cancer care. Current Opinion in Oncology 30(2): 77-83
Yamazumi, T.; Kuroda, T.; Ohata, T.; Obana, Y.; Furuta, I. 1998: Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 72(8): 813-819
García-Martos, P.; Domínguez, I.; Marín, P.; García-Agudo, R.; Aoufi, S.; Mira, J. 2001: Antifungal susceptibility of emerging yeast pathogens. Enfermedades Infecciosas y Microbiologia Clinica 19(6): 249-256
Rex, J.H.; Pfaller, M.A.; Rinaldi, M.G.; Polak, A.; Galgiani, J.N. 1993: Antifungal susceptibility testing. Clinical Microbiology Reviews 6(4): 367-381
Czaika, V.; Tietz, H.J.; Schmalreck, A.; Sterry, W.; Schultze, W. 2000: Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy. Mycoses 43(Suppl 2): 45-50
Simor, A.E.; Goswell, G.; Louie, L.; Lee, M.; Louie, M. 1997: Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the e test. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 16(9): 693-697
Pfaller, M.A.; Yu, W.L. 2001: Antifungal susceptibility testing. new technology and clinical applications. Infectious Disease Clinics of North America 15(4): 1227-1261
Pfaller, M.A. 2000: Antifungal susceptibility testing: progress and future developments. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 4(2): 55-60
Yao, Z.; Liao, W.; Wen, H. 2000: Antifungal therapy for treatment of cryptococcal meningitis. Chinese Medical Journal 113(2): 178-180
Suarez, S.; Friedlander, S.F. 1998: Antifungal therapy in children: an update. Pediatric Annals 27(3): 177-184
Lopez-De-Blanc, S.A.; Salati-De-Mugnolo, N.; Femopase, F.án.L.; Benitez, M.ón.B.; Morelatto, R.A.; Astrada-De-Verde, L.ía.; Masih, D. 2002: Antifungal topical therapy in oral chronic candidosis. a comparative study. Medicina Oral: Organo Oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal 7(4): 260-270
Marty, F.; Mylonakis, E. 2002: Antifungal use in HIV infection. Expert Opinion on PharmacoTherapy 3(2): 91-102
Anonymous 1996: Antifungals and resistance. Aids Patient Care and Stds 10(1): 54
Georgopapadakou, N.H. 2002: Antifungals targeted to protein modification: focus on protein N-myristoyltransferase. Expert Opinion on Investigational Drugs 11(8): 1117-1125
Georgopapadakou, N.H. 2000: Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase. Expert Opinion on Investigational Drugs 9(8): 1787-1796
Solovăstru, L.; Petrescu, Z.; Dobrescu, A. 1998: Antifungals, their potentials, limits and outlook. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 102(3-4): 80-82
Georgopapadakou, N.H. 1998: Antifungals: mechanism of action and resistance, established and novel drugs. Current Opinion in Microbiology 1(5): 547-557
Wright, J.M. 1997: Antifungals: use in high-risk patients. Critical Care Nursing Quarterly 20(3): 12-20
Kusunoki, S. 1997: Antiganglioside antibodies in Guillain-Barré syndrome. Internal Medicine 36(9): 599-600
Gallardo, E.; Serrano, C.; Prat, C.; Illa, I. 1996: Antiganglioside antibodies in neuropathies and motor neuronopathies. Neurologia 11(Suppl 5): 75-80
Vincent, A. 1998: Antiganglioside antibodies in peripheral neuropathies. Journal of Clinical Pathology 51(9): 641-642
Kusunoki, S. 1999: Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies. Rinsho Shinkeigaku 39(1): 93-95
Tagawa, Y.; Yuki, N.; Hirata, K. 1998: Antiganglioside antibodies in various episodes in a patient with recurrent Guillain-Barré syndrome. Journal of Neurology Neurosurgery and Psychiatry 65(6): 952
Gallardo, E.; Rojas-García, R.; Belvís, R.; Serrano-Munuera, C.; Ortiz, E.; Ortiz, N.; Grau, J.; Illa, I. 2001: Antiganglioside antibodies: when, which and for what. Neurologia 16(7): 293-297
Caudie, C.; Vial, C.; Bancel, J.; Petiot, P.; Antoine, J.C.; Gonnaud, P.M. 2002: Antiganglioside autoantibody profiles in Guillain-Barré syndrome. Annales de Biologie Clinique 60(5): 589-597
Faller, G.; Steininger, H.; Kränzlein, J.; Maul, H.; Kerkau, T.; Hensen, J.; Hahn, E.G.; Kirchner, T. 1997: Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 41(5): 619-623
Basso, D.; Gallo, N.; Zambon, C.F.; Baron, M.; Navaglia, F.; Stockreiter, E.; Di Mario, F.; Rugge, M.; Plebani, M. 2000: Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation. International Journal of Clinical and Laboratory Research 30(4): 173-178
Samygin, V.M.; Khrapova, N.P.; Spiridonov, V.A.; Stepin, A.A. 2001: Antigen 8 biosynthesis during cultivation of Burkholderia pseudomallei and B. mallei. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 50-52
Szymczyk, P.; Kiliańska, Z.M. 1999: Antigen CD44: does the presence of its isoforms have significance for diagnosis for diagnosis of colorectal cancer?. Postepy Biochemii 45(4): 249-260
Wilson, A.B.; Seilly, D.; Willers, C.; Vannais, D.B.; McGraw, M.; Waldren, C.A.; Hei, T.K.; Davies, A.; Chatterjee, A. 1999: Antigen S1, encoded by the MIC1 gene, is characterized as an epitope of human CD59, enabling measurement of mutagen-induced intragenic deletions in the AL cell system. Somatic Cell and Molecular Genetics 25(3): 147-157
Alexander, J.; Ruppert, J.; Page, D.M.; Hedrick, S.M.; Franco, A.; Ishioka, G.Y.; Grey, H.M.; Sette, A. 1995: Antigen analogs as therapeutic agents. Advances in Experimental Medicine and Biology 386: 109-118
Sette, A.; Alexander, J.; Snoke, K.; Grey, H.M. 1996: Antigen analogs as tools to study T-cell activation function and activation. Seminars in Immunology 8(2): 103-108
Grey, H.M.; Alexander, J.; Snoke, K.; Sette, A.; Ruppert, J. 1993: Antigen analogues as antagonists of the T cell receptor. Clinical and Experimental Rheumatology 11(Suppl 8): S47-S50
Gao, X.Z.; Tam, J.W. 2001: Antigen analysis of Trichomonas vaginalis trophozoite by SDS-PAGE and two-dimensional gel electrophoresis. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 19(4): 213-216
Qin, A.; Liu, Y.; Jin, W.; Lee, L.; Fadly, A. 2002: Antigen analysis of envelope gene products of avian leukosis virus subgroup J. Wei Sheng Wu Xue Bao 42(1): 99-104
Consonni, R.; Bertina, R.M. 1995: Antigen and functional expression of tissue factor in endotoxin stimulated U937 cells: regulation of activity by calcium ionophore A23187. Thrombosis and Haemostasis 74(3): 904-909
Capín, N.; Lavalle, C.; Ortiz-Ortiz, L. 1996: Antigen association of total HEp-2 cell extract in the screening of autoimmune diseases by western blot. Journal of Clinical Laboratory Analysis 10(3): 140-143
Ashok, B.T.; Ali, R. 1999: Antigen binding characteristics of experimentally-induced antibodies against hydroxyl radical modified native DNA. Autoimmunity 29(1): 11-19
Krivachenko, K.B. 2000: Antigen biosynthesis during the limitation of Yersinia pestis growth. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 86-88
Tussey, L.G.; Nair, U.Sadasivan.; Bachinsky, M.; Edwards, B.H.; Bakari, J.; Grimm, K.; Joyce, J.; Vessey, R.; Steigbigel, R.; Robertson, M.N.; Shiver, J.W.; Goepfert, P.A. 2003: Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization. Journal of Infectious Diseases 187(3): 364-374
Lubenko, A.; Savage, J. 2000: Antigen capture ELISA for platelet antibody detection: choice of conjugate influences assay result. Transfusion Medicine 10(3): 213-218
Heller, M.; Berthold, E.; Pfützner, H.; Leirer, R.; Sachse, K. 1993: Antigen capture ELISA using a monoclonal antibody for the detection of Mycoplasma bovis in milk. Veterinary Microbiology 37(1-2): 127-133
Wheat, L.J.; Connolly, P.; Haddad, N.; Le Monte, A.; Brizendine, E.; Hafner, R. 2002: Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. Antimicrobial Agents and ChemoTherapy 46(1): 248-250
Morgan, D.J.; Kreuwel, H.T.; Sherman, L.A. 1999: Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. Journal of Immunology 163(2): 723-727
Sugaya, H.; Abe, T.; Yoshimura, K.; Sasaki, O. 1993: Antigen dependent release of interleukin 5 in vitro from spleen cells of mice infected with Angiostrongylus cantonensis. International Journal for Parasitology 23(7): 865-869
Machetti, M.; Zotti, M.; Veroni, L.; Mordini, N.; Van Lint, M.T.; Bacigalupo, A.; Paola, D.; Viscoli, C. 2000: Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transplant Infectious Disease: An Official Journal of the Transplantation Society 2(3): 140-144
Numazaki, K.; Niida, Y.; Chiba, S. 1997: Antigen detection of Chlamydia trachomatis from the endocervix is not enough for screening of perinatal complications. American Journal of Obstetrics and Gynecology 176(4): 951-952
Gerber, M.A.; Tanz, R.R.; Kabat, W.; Bell, G.L.; Kaplan, E.L.; Shulman, S.T. 1997: Antigen detection test for group a beta-hemolytic streptococcal pharyngitis that is sufficiently sensitive for use without confirmatory cultures. Advances in Experimental Medicine and Biology 418: 39-40
Mishra, A.C.; Jadi, R.S.; Paramasivan, R.; Mourya, D.T. 2001: Antigen distribution pattern of West Nile virus in Culex tritaeniorhynchus, Culex vishnui and Culex pseudovishnui mosquitoes. Journal of Communicable Diseases 33(3): 174-179
Zhu, C.; Ying, D.; Zhang, W.; Sun, J.; Mi, J. 2002: Antigen expression and the biomechanical characteristics of the biologic blood vessel matrix. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 19(4): 602-605
Woodland, D.L.; Flaño, E.; Usherwood, E.J.; Liu Luzheng; Kim, I.J.; Husain, S.M.; Sample, J.T.; Blackman, M.A. 2001: Antigen expression during murine gamma-herpesvirus infection. Immunobiology 204(5): 649-658
Dufour-Gesbert, F.; Kempf, I.; De Simone, F.; Kobisch, M. 2001: Antigen heterogeneity and epitope variable expression in Mycoplasma meleagridis isolates. Veterinary Microbiology 78(3): 261-273
Agrewala, J.N.; Owais, M.; Gupta, C.M.; Mishra, G.C. 1996: Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells. Cytokines and Molecular Therapy 2(1): 59-65
Pachlopnik, J.M.; Stämpfli, M.R.; Rudolf, M.P.; Aebischer, I.; Kricek, F.; Miescher, S.; Stadler, B.M. 1998: Antigen interaction and heat inactivation expose new epitopes on human IgE. International Archives of Allergy and Immunology 117(4): 231-238
Kleijmeer, M.J.; Escola, J.M.; UytdeHaag, F.G.; Jakobson, E.; Griffith, J.M.; Osterhaus, A.D.; Stoorvogel, W.; Melief, C.J.; Rabouille, C.; Geuze, H.J. 2001: Antigen loading of MHC class i molecules in the endocytic tract. Traffic 2(2): 124-137
Wang, Y.; Xie, W.; Qiu, Y.; Gu, Z.; Zhang, X. 2000: Antigen loading on dendritic cells affects the cell function in stimulating T cells. Zhonghua Xue Ye Xue Za Zhi 21(7): 345-348
Mezzasoma, L.; Bacarese-Hamilton, T.; Di Cristina, M.; Rossi, R.; Bistoni, F.; Crisanti, A. 2002: Antigen microarrays for serodiagnosis of infectious diseases. Clinical Chemistry 48(1): 121-130
Löffler, K.U.; Simon, J.C.; Wuttig, C.; Althauser, S.R.; Bräutigam, P.; Witschel, H. 1995: Antigen pattern in choroid melanoma in correlation with immunoscintigraphy. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 92(5): 723-727
Ishibashi, H.; Shigematsu, H.; Shimoda, S.; Nakamura, M. 1999: Antigen peptide analog: induction of T cell anergy in primary biliary cirrhosis. Internal Medicine 38(2): 173-175
Kuśnierczyk, P. 1999: Antigen peptide/MHC complex as an initiator of a signal for lymphocyte T activation. Postepy Higieny i Medycyny Doswiadczalnej 53(2): 331-341
Wang, Y.; Huang, G.; Wang, J.; Molina, H.; Chaplin, D.D.; Fu, Y.X. 2000: Antigen persistence is required for somatic mutation and affinity maturation of immunoglobulin. European Journal of Immunology 30(8): 2226-2234